Veru (VERU) 10-K 12 Dec 16 2016 FY Annual report Financial data

Document And Entity Information

Document And Entity Information - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2016	Dec. 09, 2016	Mar. 31, 2016
Document And Entity Information [Abstract]
Document Type	10-K
Document Period End Date	Sep. 30, 2016
Amendment Flag	false
Entity Registrant Name	FEMALE HEALTH CO
Entity Central Index Key	863,894
Current Fiscal Year End Date	--09-30
Entity Filer Category	Accelerated Filer
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	FY
Entity Public Float			$ 50
Entity Common Stock, Shares Outstanding		31,338,249

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Sep. 30, 2016	Sep. 30, 2015
Current Assets:
Cash	$ 2,385,082	$ 4,105,814
Accounts receivable, net of allowance for doubtful accounts of $38,103 for 2016 and $48,068 for 2015	10,775,200	14,088,390
Income tax receivable	2,387	21,251
Inventory, net	2,492,644	1,745,180
Prepaid expenses and other current assets	634,588	609,320
Deferred income taxes	2,025,000	1,016,000
TOTAL CURRENT ASSETS	18,314,901	21,585,955
PLANT AND EQUIPMENT
Equipment, furniture and fixtures	4,625,472	4,680,246
Leasehold improvements	323,147	323,147
Less accumulated depreciation and amortization	(4,123,532)	(3,763,403)
Plant and equipment, net	825,087	1,239,990
Other trade receivables	7,837,500
Other assets	189,219	136,766
Deferred income taxes	11,457,000	14,509,000
TOTAL ASSETS	38,623,707	37,471,711
Current Liabilities:
Accounts payable	701,035	1,077,349
Accrued expenses and other current liabilities	2,380,571	2,555,231
Accrued compensation	264,871	592,428
TOTAL CURRENT LIABILITIES	3,346,477	4,225,008
Long-term liabilities:
Other liabilities	1,233,750
Deferred rent		15,389
Deferred income taxes	110,069	98,252
TOTAL LIABILITIES	4,690,296	4,338,649
Commitments and Contingencies
STOCKHOLDERS' EQUITY:
Preferred stock; no shares issued and outstanding in 2016 or 2015
Common stock, par value $0.01 per share; authorized 38,500,000 shares; issued 31,273,954 and 31,192,536, and 29,090,250 and 29,008,832 shares outstanding in 2016 and 2015 respectively	312,740	311,925
Additional paid-in-capital	69,660,010	69,205,201
Accumulated other comprehensive loss	(581,519)	(581,519)
Accumulated deficit	(27,651,215)	(27,995,940)
Treasury stock, at cost	(7,806,605)	(7,806,605)
TOTAL STOCKHOLDERS' EQUITY	33,933,411	33,133,062
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 38,623,707	$ 37,471,711

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Sep. 30, 2016	Sep. 30, 2015
Consolidated Balance Sheets [Abstract]
Accounts receivable, allowance for doubtful accounts	$ 38,103	$ 48,068
Preferred stock, issued	0	0
Preferred stock, outstanding	0	0
Common Stock, par value	$ 0.01	$ 0.01
Common Stock, shares authorized	38,500,000	38,500,000
Common Stock, shares issued	31,273,954	31,192,536
Common Stock, shares outstanding	29,090,250	29,008,832

Consolidated Statements Of Inco

Consolidated Statements Of Income - USD ($)	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
Consolidated Statements Of Income [Abstract]
Net revenues	$ 22,127,342	$ 32,604,865	$ 24,490,586
Cost of sales	8,777,858	13,634,906	11,369,108
Gross profit	13,349,484	18,969,959	13,121,478
Operating expenses:
Research and development	99,393	219,815	5,575
Advertising	88,866	0	58,121
Selling, general and administrative	8,660,174	12,131,737	9,133,870
Business acquisition	1,482,539
Total operating expenses	10,330,972	12,351,552	9,197,566
Operating income	3,018,512	6,618,407	3,923,912
Non-operating (expense) income:
Interest and other (expense) income, net	(57,056)	10,150	117,123
Foreign currency transaction (loss) gain	(147,540)	58,483	(83,844)
Total non-operating (expense) income	(204,596)	68,633	33,279
Income before income taxes	2,813,916	6,687,040	3,957,191
Income tax expense	2,469,191	2,341,004	1,524,130
Net income	$ 344,725	$ 4,346,036	$ 2,433,061
Net income per basic common share outstanding	$ 0.01	$ 0.15	$ 0.09
Basic weighted average common shares outstanding	28,666,477	28,532,327	28,522,525
Net income per diluted common share outstanding	$ 0.01	$ 0.15	$ 0.08
Diluted weighted average common shares outstanding	28,926,557	28,917,048	28,865,384
Cash dividends declared per common share			$ 0.21

Consolidated Statements Of Stoc

Consolidated Statements Of Stockholders’ Equity - USD ($)	Common Stock [Member]Cashless [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive Loss [Member]	Accumulated Deficit [Member]	Treasury Stock [Member]	Total
Balance at Sep. 30, 2013		$ 306,948	$ 67,460,478	$ (581,519)	$ (28,715,040)	$ (7,067,910)	$ 31,402,957
Balance (in Shares) at Sep. 30, 2013		30,694,843
Share-based compensation		$ 2,169	907,281				909,450
Share-based compensation (in Shares)		216,863
Issuance of common stock upon exercise of stock options		$ 300	117,300				117,600
Issuance of common stock upon exercise of stock options (in Shares)		30,000
Issuance of common stock upon cashless exercise of options		$ 170	(170)
Issuance of common stock upon cashless exercise of options (in Shares)	16,963	16,963
Stock repurchase – total						(737,745)	(737,745)
Common stock dividends					(6,059,997)		(6,059,997)
Net income and comprehensive income					2,433,061		2,433,061
Balance at Sep. 30, 2014		$ 309,587	68,484,889	(581,519)	(32,341,976)	(7,805,655)	28,065,326
Balance (in Shares) at Sep. 30, 2014		30,958,669
Share-based compensation		$ 2,338	720,312				722,650
Share-based compensation (in Shares)		233,867
Stock repurchase – total						(950)	(950)
Net income and comprehensive income					4,346,036		4,346,036
Balance at Sep. 30, 2015		$ 311,925	69,205,201	(581,519)	(27,995,940)	(7,806,605)	33,133,062
Balance (in Shares) at Sep. 30, 2015		31,192,536
Share-based compensation		$ 815	454,809				455,624
Share-based compensation (in Shares)		81,418
Net income and comprehensive income					344,725		344,725
Balance at Sep. 30, 2016		$ 312,740	$ 69,660,010	$ (581,519)	$ (27,651,215)	$ (7,806,605)	$ 33,933,411
Balance (in Shares) at Sep. 30, 2016		31,273,954

Consolidated Statements Of Sto6

Consolidated Statements Of Stockholders’ Equity (Parenthetical) - shares	12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cashless options, exercises in period		30,000
Treasury shares	250	169,000
Common Stock [Member]
Issuance of common stock upon exercise of stock options		30,000
Issuance of common stock upon cashless exercise of options		16,963
Common Stock [Member] | Cashless [Member]
Issuance of common stock upon cashless exercise of options		16,963

Consolidated Statements Of Cash

Consolidated Statements Of Cash Flows - USD ($)	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
OPERATIONS
Net income	$ 344,725	$ 4,346,036	$ 2,433,061
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Depreciation and amortization	422,873	494,258	589,343
Provision for obsolete inventory	(8,630)	173,634	37,603
Provision for bad debts			38,068
Share-based compensation	499,873	489,689	858,615
Deferred income taxes	2,054,817	1,925,739	1,012,334
Loss on disposal of fixed assets	699	3,483	491
Changes in operating assets and liabilities:
Accounts receivable	(4,524,310)	(11,144,540)	(619,753)
Income tax receivable	18,864	(21,251)	78,440
Inventories	(738,834)	1,064,633	(561,633)
Prepaid expenses and other assets	(77,721)	58,241	(151,656)
Accounts payable	(376,314)	(47,510)	220,810
Accrued expenses and other current liabilities	669,600	1,108,891	(270,310)
Net cash (used in) provided by operating activities	(1,714,358)	(1,548,697)	3,665,413
INVESTING ACTIVITIES
Capital expenditures	(6,374)	(135,424)	(97,311)
Net cash used in investing activities	(6,374)	(135,424)	(97,311)
FINANCING ACTIVITIES
Proceeds from exercise of stock options			117,600
Purchases of common stock for treasury shares		(950)	(737,745)
Dividends paid on common stock		(5,338)	(6,074,164)
Net cash used in financing activities		(6,288)	(6,694,309)
Net decrease in cash	(1,720,732)	(1,690,409)	(3,126,207)
Cash at beginning of year	4,105,814	5,796,223	8,922,430
CASH AT END OF YEAR	2,385,082	4,105,814	5,796,223
Supplemental Disclosure of Cash Flow Information:
Cash payments for income taxes	352,856	294,441	773,041
Schedule of noncash financing and investing activities:
Dividends payable			6,913
Reduction of accrued expense upon issuance of shares	19,785	$ 255,577	$ 311,515
Fixed asset additions in accounts payable at year end	$ 2,295

Nature Of Business And Signific

Nature Of Business And Significant Accounting Policies	12 Months Ended
	Sep. 30, 2016
Nature Of Business And Significant Accounting Policies [Abstract]
Nature of Business and Significant Accounting Policies	Note 1. Nature of Business and Significant Accounting Policies  Principles of consolidation and nature of operations : The consolidated financial statements include the accounts of The Female Health Company (FHC or the Company) and its wholly owned subsidiary, The Female Health Company – UK, and its wholly owned subsidiaries, The Female Health Company - UK, plc and The Female Health Company (M) SDN.BHD. All significant intercompany transactions and accounts have been eliminated in consolidation. Prior to t he completion of the merger transaction with APP (see note 14), t he Company had been a single product company engaged in the marketing, manufacture and distribution of a consumer health care product, the FC2 female condom (FC2). The Female Health Company - UK, is the holding company of The Female Health Company - UK, plc, which is located in a 6,400 sq. ft. leased office facility located in London, England (collectively the U.K. subsidiary). The Female Health Company (M) SDN.BHD leases a 45,800 sq. ft. manufacturing facility located in Selangor D.E., Malaysia (the Malaysia subsidiary).  FC2 has been distributed in either or both commercial (private sector) and public health sector markets in 144 countries. It is marketed to consumers through distributors, public health programs and retailers in 16 countries.  The Company's standard credit terms vary from 30 to 120 days, depending on the class of trade and customary terms within a territory, so accounts receivable is affected by the mix of purchasers within the period. As is typical in the Company's business, extended credit terms may occasionally be offered as a sales promotion or for certain sales. The Company has agreed to credit terms of up to 150 days with our distributor in the Republic of South Africa. For the most recent order of 15 million units under the Brazil tender, the Company has agreed to up to 360 day credit terms with our distributor in Brazil subject to earlier payment upon receipt of payment by the distributor from the Brazilian Government. For the past twelve months, the Company's average days’ sales outstanding was approximately 304 days. Over the past five years, the Company’s bad debt expense has been less than 0.02 percent of product sales.  Use of estimates : The preparation of financial statements requires management to make estimates and use assumptions that affect certain reported amounts and disclosures. Significant accounting estimates include the deferred income tax valuation allowance and the value of share-based compensation. Actual results may differ from those estimates.  Cash concentration : The Company’s cash is maintained primarily in three financial institutions, located in Chicago, Illinois, London, England and Kuala Lumpur, Malaysia, respectively.  Accounts receivable and concentration of credit risk : Accounts receivable are carried at original invoice amount less an estimate made for doubtful receivables based on a review of all outstanding amounts on a periodic basis. The components of accounts receivable consist of the following at September 30, 2016 and 2015 :     2016 2015   Trade receivables $ 18,616,342 $ 13,975,905  Other receivables 34,461 160,553  Accounts receivable, gross 18,650,803 14,136,458  Less: allowance for doubtful accounts (38,103) (48,068)  Accounts receivable, net 18,612,700 14,088,390  Less: long-term trade receivables (7,837,500) —  Current accounts receivable, net $ 10,775,200 $ 14,088,390  The Company has long-term trade receivables that may not be collectable within one year of the balance sheet date based on the credit terms with our Brazil distributor.  The Company maintains an allowance for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments on accounts receivable. Management determines the allowance for doubtful accounts by identifying troubled accounts and by using historical experience applied to an aging of accounts. Management also periodically evaluates individual customer receivables and considers a customer’s financial condition, credit history, and the current economic conditions. Accounts receivable are written-off when deemed uncollectible. The table below sets forth the components of the allowance for doubtful accounts for the years ended September 30:      Balance at Provision Charges Write offs/ Balance at  Year October 1 to Expenses Recoveries September 30  2014 $ 13,180 $ 38,068 $ (3,180) $ 48,068  2015 $ 48,068 $ — $ — $ 48,068  2016 $ 48,068 $ — $ (9,965) $ 38,103 R ecoveries of accounts receivable previously written-off are recorded when received. The Company’s customers are primarily large global agencies, non-government organizations, ministries of health and other governmental agencies which purchase and distribute the female condom for use in HIV/AIDS prevention and family planning programs. In fiscal year 2016 and fiscal year 2015, our significant customers were Semina Indústria e Comércio Ltda (Semina), United Nations Population Fund (UNFPA), and the United States Agency for International Development (USAID). In fiscal year 2014, our significant customers were UNFPA, USAID, Sekunjalo Investments Corporation (PTY) Ltd (Sekunjalo), and Azinor International Lda (Azinor). No other single customer accounted for more than 10 percent of unit sales during those periods.      Percentage of Unit Sales  Significant Customers 2016 2015 2014  Semina 27% 47% *  UNFPA 25% 18% 40%  USAID 24% 16% 17%  Sekunjalo * * 13%  Azinor * * 11%  Total Percentage of Unit Sales 76% 81% 81% _____________________  * Less than 10 percent of unit sales.  Semina’s current accounts receivable balance represented 44 percent and 46 percent of current assets at September 30, 2016 and 2015, respectively. No other single customer’s accounts receivable balance accounted for more than 10 percent of current assets at the end of those periods. Semina’s total accounts receivable balance represented 85 percent and 71 percent of trade receivables at September 30, 2016 and 2015, respectively.  Inventory : Inventories are valued at the lower of cost or market. The cost is determined using the first-in, first-out (FIFO) method. Inventories are also written down for management’s estimates of product which will not sell prior to its expiration date. Write-downs of inventories establish a new cost basis which is not increased for future increases in the market value of inventories or changes in estimated obsolescence.  Foreign currency translation and operations : Effective October 1, 2009, the Company determined that there were significant changes in facts and circumstances, triggering an evaluation of its subsidiaries’ functional currency. The evaluation indicated that the U.S. dollar is the currency with the most significant influence upon the subsidiaries. Because all of the U.K. subsidiary's future sales and cash flows would be denominated in U.S. dollars following the October 2009 cessation of production of the Company’s first generation product, FC1, the U.K. subsidiary adopted the U.S. dollar as its functional currency effective October 1, 2009. As the Malaysia subsidiary is a direct and integral component of the U.K. parent’s operations, it, too, adopted the U.S. dollar as its functional currency as of October 1, 2009. The consistent use of the U.S. dollar as functional currency across the Company reduces its foreign currency risk and stabilizes its operating results. The Company recognized a foreign currency transaction loss of $ 147,540 , a foreign currency transaction gain of $ 58,483 , and a foreign currency transaction loss of $ 83,844 for the years ended September 30, 2016, 2015, and 2014 , respectively. The cumulative foreign currency translation loss included in accumulated other comprehensive loss was $581,519 as of September 30, 2016 and 2015 . Assets located outside of the U.S. totaled approximately $5,500,000 and $10,000,000 at September 30, 2016 and 2015 , respectively.  Equipment, furniture and fixtures : Depreciation and amortization are computed using primarily the straight-line method. Depreciation and amortization are computed over the estimated useful lives of the respective assets which range as follows:      Manufacturing equipment 5 – 10 years  Office equipment 3 – 5 years  Furniture and fixtures 7 – 10 years  Depreciation on leased assets is computed over the lesser of the remaining lease term or the estimated useful lives of the assets. Depreciation on leased assets is included with depreciation on owned assets.  Patents and trademarks : The costs for patents and trademarks are expensed when incurred. FC2 patents have been issued by the United States, Europe, Canada, Australia, South Africa, the People’s Republic of China, Japan, Mexico, Brazil, India and the African Regional Intellectual Property Organization (ARIPO), which includes Botswana, Gambia, Ghana, Kenya, Lesotho, Malawi, Mozambique, Namibia, Sierra Leone, Sudan, Swaziland, Tanzania, Uganda, Zambia, and Zimbabwe. Further, the European patent for FC2 has been validated in the following countries: Austria, Belgium, Bulgaria, Switzerland, Republic of Cyprus, Czech Republic, Germany, Denmark, Estonia, Spain, Finland, France, United Kingdom, Greece, Hungary, Ireland, Italy, Luxembourg, Monaco, Netherlands, Portugal, Romania, Sweden, Slovenia, Slovakia, and Turkey. The patents cover the key aspects of FC2, including its overall design and manufacturing process. The patents have expiration dates in 2023 and 2024.  The Company has a registration for the trademark “FC2 Female Condom” in the United States. Furthermore, the Company has filed applications or secured registrations in 40 countries or jurisdictions around the world to protect the various names and symbols used in marketing its Female Condoms. In addition, the experience that has been gained through years of manufacturing its Female Condoms (FC1 and FC2) has allowed the Company to develop trade secrets and know-how, including certain proprietary production technologies, that further protect its competitive position.  Financial instruments : The Company follows ASC Topic 820, Fair Value Measurements and Disclosures , which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. The fair value framework requires the categorization of assets and liabilities into three levels based upon the assumptions (inputs) used to price the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment.  The Company currently does not have any assets or liabilities measured at fair value on a recurring or non-recurring basis. Substantially all of the Company’s cash, as well as restricted cash, are held in demand deposits with three financial institutions. The Company has no financial instruments for which the carrying value is materially different than fair value.  Research and development costs : Research and development costs are expensed as incurred. The amount of costs expensed for the years ended September 30, 2016, 2015, and 2014 were $99,393 , $219,815 , and $5,575 , respectively.  Restricted cash : Restricted cash relates to security provided to one of the Company’s U.K. banks for performance bonds issued in favor of customers. The Company has a facility of $250,000 for such performance bonds. Such security has been extended infrequently and only on occasions where it has been a contract term expressly stipulated as an absolute requirement by the customer or its provider of funds. The expiration of the bond is defined by the completion of the event such as, but not limited to, a period of time after the product has been distributed or expiration of the product shelf life. Restricted cash was $ 134,443 and $ 85,697 for the years ended September 30, 2016 and 2015 , respectively, and is included in cash on the accompanying balance sheets.  Revenue recognition : The Company recognizes revenue from product sales when each of the following conditions has been met: an arrangement exists, delivery has occurred, there is a fixed price, and collectability is reasonably assured.  Share-based compensation : The Company accounts for stock-based compensation expense for equity awards exchanged for services over the vesting period based on the grant-date fair value. In many instances, the equity awards are issued upon the grant date subject to vesting periods. In certain instances, the equity awards provide for future issuance contingent on future continued employment or performance of services as of the issuance date.  Advertising : The Company's policy is to expense advertising costs as incurred. Advertising costs were $ 88,866 , $0 , and $ 58,121 for the years ended September 30, 2016, 2015, and 2014 , respectively.  Income taxes : The Company files separate income tax returns for its foreign subsidiaries. ASC Topic 740 requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial statements and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Deferred tax assets are also provided for carryforwards for income tax purposes. In addition, the amount of any future tax benefits is reduced by a valuation allowance to the extent such benefits are not expected to be realized.  Earnings per share (EPS) : Basic EPS is computed by dividing net income by the weighted average number of common shares outstanding for the period. Diluted EPS is computed by dividing net income by the weighted average number of common shares outstanding during the period after giving effect to all dilutive potential common shares that were outstanding during the period. Dilutive potential common shares consist of the incremental common shares issuable upon the exercise of stock options and unvested shares granted to employees and directors. Other comprehensive income : Accounting principles generally require that recognized revenue, expenses, gains and losses be included in net income. Although certain changes in assets and liabilities, such as foreign currency translation adjustments, are reported as a separate component of the equity section of the accompanying consolidated balance sheets, these items, along with net income, are components of comprehensive income.  The U.S. parent company and its U.K. subsidiary routinely purchase inventory produced by its Malaysia subsidiary for sale to their respective customers. These intercompany trade accounts are eliminated in consolidation. The Company’s policy and intent is to settle the intercompany trade account on a current basis. Since the U.K. and Malaysia subsidiaries adopted the U.S. dollar as their functional currencies effective October 1, 2009, no foreign currency gains or losses from intercompany trade are recognized. In fiscal 2016, 2015, and 2014 , comprehensive income is equivalent to the reported net income.  Recently issued accounting pronouncements : In November 2015, the Financial Accounting Standards Board (FASB) issued ASU 2015-17, Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes. The amendments in this Update require that deferred tax liabilities and assets be classified as non-current in a classified statement of financial position. Current accounting principles require an entity to separate deferred income tax liabilities and assets into current and non-current amounts in a classified statement of financial position. ASU 2015-17 will be effective for the Company beginning on October 1, 2017.  In May 2014, the FASB issued ASU 2014-09 “Revenue from Contracts with Customers” (Topic 606). This new accounting guidance on revenue recognition provides for a single five-step model to be applied to all revenue contracts with customers. The new standard also requires additional financial statement disclosures that will enable users to understand the nature, amount, timing and uncertainty of revenue and cash flows relating to customer contracts. ASU 2014-09 will be effective for the Company beginning on October 1, 2018. We are currently evaluating the impact of the new guidance on our consolidated financial statements and have not yet selected a transition approach to implement the standard.  In July 2015, the FASB issued ASU 2015-11, Inventory (Topic 330): Simplifying the Measurement of Inventory. This new accounting guidance more clearly articulates the requirements for the measurement and disclosure of inventory. Topic 330, Inventory, currently requires an entity to measure inventory at the lower of cost or market. Market could be replacement cost, net realizable value, or net realizable value less an approximately normal profit margin. This new accounting guidance requires the measurement of inventory at the lower of cost or net realizable value. ASU 2015-11 will be effective for the Company beginning on October 1, 2017. The adoption of this guidance is not expected to have a material impact on our consolidated financial statements.  In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). The amendments in this Update increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. ASU 2016-02 will be effective for the Company beginning on October 1, 2019. We are currently evaluating the impact of the new guidance on our consolidated financial statements and have not yet selected a transition approach to implement the standard.  In March 2016, the FASB issued ASU 2016-09, Compensation – Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting. The amendments in this Update simplify the income tax effects, minimum statutory tax withholding requirements and impact of forfeitures related to how share-based payments are accounted for and presented in the financial statements. ASU 2016-09 will be effective for the Company beginning on October 1, 2017. We are currently evaluating the impact of the new guidance on our consolidated financial statements and have not yet selected a transition approach to implement the standard.

Earnings Per Share

Earnings Per Share	12 Months Ended
	Sep. 30, 2016
Earnings Per Share [Abstract]
Earnings Per Share	Note 2. Earnings per Share  Basic EPS is computed by dividing net income by the weighted average number of common shares outstanding for the period. Diluted EPS is computed by dividing net income by the weighted average number of common shares outstanding during the period after giving effect to all dilutive potential common shares that were outstanding during the period. Dilutive potential common shares consist of the incremental common shares issuable upon the exercise of stock options and unvested shares granted to employees and directors .     Year Ended September 30,  Denominator 2016 2015 2014  Weighted average common shares outstanding - basic 28,666,477 28,532,327 28,522,525  Net effect of dilutive securities:  Options 11,443 50,473 109,583  Unvested restricted shares 248,637 334,248 233,276  Total net effect of dilutive securities 260,080 384,721 342,859  Weighted average common shares outstanding - diluted 28,926,557 28,917,048 28,865,384  Income per common share – basic $ 0.01 $ 0.15 $ 0.09  Income per common share – diluted $ 0.01 $ 0.15 $ 0.08  Options to purchase approximately 90,000 and 17,500 shares of common stock at exercise prices of $3.92 per share and $1.82 per share, respectively, that were both outstanding for the year end ed September 30, 201 6 were not included in the computation of diluted net income per share because their effect was anti-dilutive. Options to purchase approximately 90,000 shares of common stock at an exercise price of $3.92 per share that were outstanding for the year ended September 30, 2015 were not included in the computation of diluted net income per share because their effect was anti-dilutive. All other outstanding stock options were included in the computation of diluted net income per share for the years ended September 30, 2016, 2015, and 2014 .

Inventory

Inventory	12 Months Ended
	Sep. 30, 2016
Inventory [Abstract]
Inventory	Note 3. Inventory  The components of inventory consist of the following at September 30, 2016 and 2015 :      2016 2015   Raw material $ 670,802 $ 839,179  Work in process — 77,483  Finished goods 1,834,958 868,270  Inventory, gross 2,505,760 1,784,932  Less: inventory reserves (13,116) (39,752)  Inventory, net $ 2,492,644 $ 1,745,180  The change in the inventory reserve for the years ended September 30 is as follows:      Balance at Charged to Costs Balance at  Year October 1 and Expenses Write-offs September 30  2014 $ 41,133 $ 37,603 $ (17,863) $ 60,873  2015 $ 60,873 $ 173,634 $ (194,755) $ 39,752  2016 $ 39,752 $ (8,630) $ (18,006) $ 13,116  

Line of Credit

Line of Credit	12 Months Ended
	Sep. 30, 2016
Line of Credit [Abstract]
Line of Credit	Note 4. Revolving Line of Credit  On August 1, 2015, the Company entered into an amendment to the Second Amended and Restated Loan Agree ment (as amended, the Loan Agreement) with Midland States Bank to extend the term of the Company’s revolving line of credit to August 1, 2016 . The credit facility consisted of a single revolving note for up to $2 million with Midland States Bank, with borrowings limited to a borrowing base determined based on 70 percent to 80 percent of eligible accounts receivable plus 50 percent of eligible inventory. Significant restrictive covenants in the Loan Agreement included prohibitions on any merger, consolidation or sale of all or a substantial portion of the Compa ny’s assets, and limits on the payment of dividends or the repurchase of shares. The Loan Agreement did not con tain any financial covenants that required compliance with ratios or amounts. Dividends and share repurchases were permitted as long as after giving effect to the dividend or share repurchase the Company had a ratio of total liabilities to total stockholders’ equity of no more than 1:1 . Borrowings on the revolving note were to bear interest at the national prime rate published by the Wall Street Journal ( 3.25 percent at September 30, 2015). The note was collateralized by substantially all of the assets of the Company. No amounts were outstanding under the revolving note at September 30, 2015.  On December 29, 2015, the Company and Midland States Bank terminated the Loan Agreement. There was no penalty related to the early termination of the Loan Agreement and no amounts wer e outstanding under this facili ty.  On December 29, 2015, the Company entered into a Credit Agreement (the Credit Agreement) with BMO Harris Bank N.A. (BMO Harris Bank). The Credit Agreement provides the Company with a revolving line of credit of up to $10 million with a term that extends to December 29, 2017 . Borrowings under the Credit Agreement bear interest, at the Company’s option, at a base rate or at LIBOR plus 2.25% . The Company is also required to pay a commitment fee at the rate of 0.10% per annum on the average daily unused portion of the revolving line of credit. The Company's obligations under the Credit Agreement are secured by a lien against substantially all of the assets of the Company and a pledge of 65% of the outstanding shares of The Female Health Company Limited. In addition to other customary representations, covenants and default provisions, the Company is required to maintain a minimum tangible net worth and to not to exceed a maximum total leverage ratio. Among the non-financial covenants, the Company is restricted in its ability to pay dividends, buy back shares of its common stock, incur additional debt and make acquisitions above certain amounts. No amounts were outstanding under the Credit Agreement at September 30, 2016 .  The completion of the merger transaction with APP (see note 14) resulted in a default in FHC's compliance with certain covenants in the Credit Agreement and will constitute an "event of default" under the Credit Agreement.  On November 28, 2016, FHC, Badger Acquisition Sub, Inc., APP and BMO Harris Bank entered into a Third Amendment to the Credit Agreement (the Amendment). Pursuant to the Amendment, BMO Harris Bank waived the defaults in FHC's compliance with the covenants in the Credit Agreement as a result of the completion of the merger transaction with APP and APP became a co-borrower under the Credit Agreement . As a result, the revolving line of credit remains in effect under the terms of the Credit Agreement until the end of its term on December 29, 2017 . 

Operating Leases And Rental Exp

Operating Leases And Rental Expense	12 Months Ended
	Sep. 30, 2016
Operating Leases And Rental Expense [Abstract]
Operating Leases And Rental Expense	Note 5 . Operating Leases and Rental Expense  The Company leases approximately 6,600 square feet of office space located in Chicago, Illinois. On May 11, 2016, the Company signed a new lease, effective November 1, 2016, for this office space for a seven year period commencing on November 1, 2016 and ending on October 31, 2023. The lease grants the Company a seven month lease holiday beginning November 1 , 2016, a five month lease abatement beginning June 1 , 2017, and provides a tenant improvement allowance. The lease requires escalating monthly payments ranging from $5,833 to $9,285 , plus real estate taxes , utilities and maintenance expenses from June 1, 201 7 to October 31, 20 23 . The Company also has a renewal option to extend the term of the lease for a period of five years. Based on the terms of the lease agreement, the Company was required to make a security deposit of $55,000 .  The Company moved into the office space in September 2016. Previously the Company leased 5,100 square feet of office space. The office space had a five year lease period from November 1, 2011 and ended on October 31, 2016. The lease payment for October 2016 was recorded in September 2016.  The Company leases 6,400 square feet of office space located in London, England. The lease expires in June 2020 . The lease requires quarterly payments of approximately $13,500 through December 2011, quarterly payments of approximately $27,000 from January 2012 through June 2015 and quarterly payments of approximately $24,000 from June 20 16 through June 2020 . Based on the terms of the lease agreement, the Company was also required to make a security deposit equivalent to six months’ rent (approximately $ 59,000 ).  The Company leases 45,800 square feet of manufacturing space in Selangor D.E., Malaysia under a lease that requires monthly payments of approximately $15,000 through August 201 9 and may be renewed at the option of the Company for an additional three year term.  The Company also leases equipment under a number of lease agreements which expire at various dates through September 2021 . The aggregate monthly rental was $ 1,265 at September 30, 2016 . Details of operating lease expense, including real estate taxes and insurance, for the years ended September 30, 2016, 2015, and 2014 are as follows:      2016 2015 2014  Factory and office leases $ 455,956 $ 470,049 $ 439,722  Other 15,176 7,387 4,758  Total $ 471,132 $ 477,436 $ 444,480  Future minimum payments under leases consist of the following as of September 30, 2016 :     Operating  Leases  2017 $ 345,301  2018 401,624  2019 401,904  2020 186,305  2021 110,803  Thereafter 228,298  Total minimum lease payments $ 1,674,235  

Income Taxes

Income Taxes	12 Months Ended
	Sep. 30, 2016
Income Taxes [Abstract]
Income Taxes	Note 6. Income Taxes  The Company accounts for income taxes using the liability method, which requires the recognition of deferred tax assets or liabilities for the tax-effected temporary differences between the financial reporting and tax bases of assets and liabilities, and for net operating loss and tax credit carryforwards.  The Company completes a detailed analysis of its deferred income tax valuation allowance on an annual basis or more frequently if information comes to our attention that would indicate that a revision to its estimates is necessary. In evaluating the Company’s ability to realize its deferred tax assets, management considers all available positive and negative evidence on a country by country basis, including past operating results and forecast of future taxable income. In determining future taxable income, management makes assumptions to forecast U.S. federal and state, U.K. and Malaysia operating income, the reversal of temporary differences, and the implementation of any feasible and prudent tax planning strategies. These assumptions require significant judgment regarding the forecasts of the future taxable income in each tax jurisdiction, and are consistent with the forecasts used to manage the Company’s business. It should be noted that the Company realized significant losses through 2005 on a consolidated basis. Since fiscal year 2006, the Company has consistently generated taxable income on a consolidated basis, providing a reasonable future period in which the Company can reasonably expect to generate taxable income. In management’s analysis to determine the amount of the deferred tax asset to recognize, management projected future taxable income for each tax jurisdiction.  Although management uses the best information available, it is reasonably possible that the estimates used by the Company will be materially different from the actual results. These differences could have a material effect on the Company's future results of operations and financial condition.  Income before income taxes was taxed by the following jurisdictions for the years ended September 30, 2016, 2015, and 2014 :      2016 2015 2014  Domestic $ 1,068,580 $ 4,524,499 $ 2,837,835  Foreign 1,745,336 2,162,541 1,119,356  Total $ 2,813,916 $ 6,687,040 $ 3,957,191  A reconciliation of income tax expense and the amount computed by applying the statutory Federal income tax rate to income before income taxes for the years ended September 30, 2016, 2015, and 2014 is as follows:      2016 2015 2014  Income tax expense at statutory rates $ 957,000 $ 2,274,000 $ 1,345,000  State income tax, net of federal benefits 149,000 362,000 248,000  Non-deductible expenses - other 50,000 51,000 (5,000)  Non-deductible business acquisition expenses 556,000 — —  Effect of lower foreign income tax rates (305,648) (351,244) (175,632)  Effect of change in U.K. tax rate 1,251,000 — —  Effect of reinvestment allowance - Malaysia — — (9,000)  Effect of export allowance - Malaysia — (85,000) —  Effect of change in Illinois tax rate — 202,000 —  Effect of conversion of charitable contribution to NOL — (36,174) —  Other 87,839 (59,578) 56,762  Change in valuation allowance (18,000) (16,000) 64,000  Effect of UK tax rate change on valuation allowance (258,000) — —  Income tax expense $ 2,469,191 $ 2,341,004 $ 1,524,130  As of September 30, 2016 , the Company had federal and state net operating loss carryforwards of approximately $ 8,105,000 and $ 7,825,000 , respectively, for income tax purposes expiring in years 202 1 to 2027 . The Company's U.K. subsidiary has U.K. net operating loss carryforwards of approximately $ 60,863,000 as of September 30, 2016 , which can be carried forward indefinitely to be used to offset future U.K. taxable income.  The federal and state income tax expense (benefit) for the years ended September 30, 2016, 2015, and 2014 is summarized below:      2016 2015 2014  Deferred – U.S. $ 881,000 $ 1,856,000 $ 561,000  Deferred – U.K. 1,162,000 162,000 496,000  Deferred – Malaysia 11,817 (92,261) (44,666)  Subtotal 2,054,817 1,925,739 1,012,334  Current – U.S. 104,000 83,606 219,000  Current – Malaysia 310,374 331,659 292,796  Current - U.K. — — —  Subtotal 414,374 415,265 511,796  Income tax expense $ 2,469,191 $ 2,341,004 $ 1,524,130  Significant components of the Company's deferred tax assets and liabilities are as follows at September 30, 2016 and 2015 :      Deferred Tax Assets 2016 2015  Federal net operating loss carryforwards $ 2,756,000 $ 4,428,000  State net operating loss carryforwards 400,000 644,000  AMT credit carryforward 489,000 390,000  Foreign net operating loss carryforwards – U.K. 10,955,000 12,388,000  Foreign capital allowance – U.K. 112,000 114,000  Other, net - Malaysia 9,850 13,097  Restricted stock – U.K. 1,000 —  Share-based compensation 101,000 128,000  Deemed dividend - Malaysia 942,000 —  Other, net - U.S. 25,000 8,000  Gross deferred tax assets 15,790,850 18,113,097  Valuation allowance for deferred tax assets (2,299,000) (2,575,000)  Net deferred tax assets 13,491,850 15,538,097  Deferred Tax Liabilities:  Foreign capital allowance – Malaysia (119,919) (111,349)  Net deferred tax assets $ 13,371,931 $ 15,426,748  The deferred tax amounts have been classified in the accompanying consolidated balance sheets at September 30 as follows:      2016 2015  Current assets – U.S. $ 2,020,000 $ 854,000  Current assets – U.K. 5,000 162,000  Total current assets 2,025,000 1,016,000  Long-term assets – U.S. 2,693,000 4,740,000  Long-term assets – U.K 8,764,000 9,769,000  Total long-term assets 11,457,000 14,509,000  Long-term liability – Malaysia (110,069) (98,252)  $ 13,371,931 $ 15,426,748  The change in the valuation allowance for deferred tax assets for the years ended September 30 is as follows:      Balance at Charged to Costs Balance at  Year October 1 and Expenses Deductions/Other September 30  2014 $ 2,147,000 $ 432,000 $ 12,000 $ 2,591,000  2015 $ 2,591,000 $ (16,000) $ — $ 2,575,000  2016 $ 2,575,000 $ (276,000) $ — $ 2,299,000  The valuation allowance decreased by $ 276,000 , decreased by $ 16,000 , and increased by $ 444,000 for the years ended September 30, 2016, 2015, and 2014 , respectively. Under the Internal Revenue Code, certain ownership changes, including the prior issuance of preferred stock, the public offering of common stock and the exercise of common stock warrants and options may subject the Company to annual limitations on the utilization of its net operating loss carryforward. Under the Inland Revenue statutes, certain triggering events may subject the Company to limitations on the utilization of its net operating loss carryforward in the U.K. As of September 30, 2016 , management does not believe any limitations have occurred.  The Company has not recorded any other deferred income taxes applicable to undistributed earnings of foreign subsidiaries because it is the present intention of management to reinvest the undistributed earning s indefinitely. Generally such earnings become subject to U.S. tax upon remittance of dividends and under certain other circumstances. It is not practicable to estimate the amount of deferred tax or such undistributed earnings.  ASC Topic 740 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740 developed a two-step process to evaluate a tax position and also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. The Company has not recorded a reserve for any tax positions for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility.  The Company files tax returns in all appropriate jurisdictions, including foreign, U.S. Federal and Illinois and Virginia State tax returns. The following summarizes open tax years in the relevant jurisdictions:  · For the U.S., a tax return may be audited any time within 3 years from filing date. The U.S. open tax years are for fiscal years 201 3 through 201 5 , which expire in years 201 7 through 201 9 , respectively.  · For Malaysia, a tax return may be audited any time within 5 years from filing date ( 7 months after the fiscal year end). The Malaysia open tax years are for 201 1 through 201 5 , which expire on December 31, 201 6 through 20 20 .  · For the U.K., a tax return may be audited within 1 year from the later of: the filing date or the filing deadline ( 1 year after the end of the accounting period). T he U.K. open tax year is for 201 5, which expires in 2017 .  The fiscal year 2016 tax returns for each jurisdiction have not been filed as of the date of this filing. As of September 30, 2016 and 2015 , the Company has no recorded liability for unrecognized tax benefits.  The Company recognizes interest and penalties related to uncertain tax positions as income tax expense as incurred. No expense for interest and penalties was recognized for the years ended September 30, 2016, 2015, and 2014 .  

Equity And Share-Based Payments

Equity And Share-Based Payments	12 Months Ended
	Sep. 30, 2016
Equity And Share-Based Payments [Abstract]
Equity And Share-Based Payments	Note 7. Equity and Share-based Payments  In March 2008, the Company’s shareholders approved the 2008 Stock Incentive Plan which is utilized to provide equity opportunities and performance–based incentives to attract, retain and motivate those persons who make (or are expected to make) important contributions to the Company. A total of 2 million shares are available for issuance under the plan. As of September 30, 2016 , a total of 1,471,302 shares had been granted under the plan and not forfeited or are subject to outstanding commitments to issue shares under the Plan , of which 167,500 shares were in the form of stock options and the remainder were in the form of restricted stock or other share grants.  Stock Option Plans  Under the Company’s previous share-based long-term incentive compensation plan, the 1997 Stock Option Plan, the Company granted non-qualified stock options to employees , directors, and consultants . There are no shares available for grant under this plan which expired on December 31, 2006 . Options issued under this plan expire 10 years after the date of grant and generally vested 1/36 per month, with full vesting after three years. Under the Company’s 2008 Stock Incentive Plan, options issued in May 2009 expire 10 years after the date of grant and vest 1/36 per month, with full vesting after three years.  The Company granted 17,500 options to employees under the 2008 Stock Incentive Plan during fiscal year 2016. Options issued under this plan expire in 10 years with vesting over a two -year period with one -half vesting on the first anniversary of the grant date and one -half vesting on the second anniversary of the grant date. The Company did not grant any options during fiscal years 2015 or 2014 . Based on the Company’s history of prior forfeitures and future expectations it was determined that there would be no forfeiture rate used.  Compensation expense is recognized only for share-based payments expected to vest. Stock compensation expense related to options was approximately $5,000 for the year ended September 30, 2016 . No sto ck compensation expense related to options was recognized for the years ended September 30, 2015 and 2014 .  The following table outlines the weighted average assumptions for options granted during the year ended September 30, 2016 :      Expected Volatility 43.19%  Expected Dividend Yield 0.00%  Risk-free Interest Rate 1.53%  Expected Term (in years) 6  Fair Value of Options Granted $ 0.78  During the year ended September 30, 2016 , the Company used historical volatility of our common stock over a period equal to the expected life of the options to estimate their fair value. The dividend yield assumption is based on the Company’s history and expectation of future dividend payouts on the common stock. The risk-free interest rate is based on the implied yield available on U.S. treasury zero-coupon issues with an equivalent remaining term.  The expected term of the options represents the estimated period of time until exercise and is based on the simplified method. To value options granted for actual stock-based compensation, the Company used the Black-Scholes option valuation model. When the measurement date is certain, the fair value of each option grant is estimated on the date of grant and is based on the assumptions used for the expected stock price volatility, expected term, risk-free interest rates and future dividend payments.  Option Activity  The following table summarizes the stock options outstanding and exercisable at September 30, 2016 :      Weighted Average  Remaining Aggregate  Exercise Price Contractual Term Intrinsic  Shares Per Share (years) Value  Outstanding at September 30, 2013 240,000 $ 2.64  Granted — —  Exercised (60,000) 2.79  Forfeited — —  Outstanding at September 30, 2014 180,000 $ 2.60  Granted — —  Exercised — —  Forfeited — —  Outstanding at September 30, 2015 180,000 $ 2.60  Granted 17,500 1.82  Exercised — —  Forfeited — —  Outstanding at September 30, 2016 197,500 $ 2.53 2.06 $ —  Exercisable on September 30, 2016 180,000 $ 2.60 1.34 $ —  No stock options were exercised during the year s ended September 30, 2016 or September 30, 2015 . During the year ended September 30, 2014 , stock option holders exercised 60,000 stock options, 30,000 shares using the cashless exercise option available under the plan which entitled them to 16,963 shares of common stock and 30,000 shares using the cash exercise option available under the plan resulting in cash proceeds of $117,600 .  The aggregate intrinsic value in the table above is before income taxes, based on the Company’s closing stock price of $ 1.22 on the last day of business for the period ended September 30, 2016 . The total intrinsic value of options e xercised during the years ended September 30, 2016, 2015, and 2014 , was approximately $0 , $0 , and $154,000 , respectively . As of September 30, 2016 , the Company had unrecognized compensation expense of $8,601 related to unveste d stock options. These expenses will be recognized over approximately 1.5 years.  Restricted Stock  The Company issues restricted stock to employees, directors and consultants. Such issuances may have vesting periods that range from one to three years. In addition, the Company has issued stock awards to certain employees and directors that provide for future issuance contingent on continued employment or performance of services for p eriods that range from one to three years.  A summary of the non-vested stock activity for fiscal years 2016, 2015, and 2014 is summarized in the table below:      Weighted Average  Grant -Date  Shares Fair Value Vesting Period  Total Outstanding September 30, 2013 33,502 $ 6.80  Stock Granted 213,576 7.80 September 2014 - December 2016  Vested (105,393) 8.15  Forfeited (250) 9.68  Total Outstanding September 30, 2014 141,435 $ 7.30  Stock Granted 293,500 1.70 September 2015 - August 2018  Vested (92,963) 4.70  Forfeited (58,250) 7.36  Total Outstanding September 30, 2015 283,722 $ 2.31  Stock Granted 101,250 1.52 September 2016 - January 2019  Vested (167,336) 2.73  Forfeited — —  Cash Election (27,666) 1.58  Total Outstanding September 30, 2016 189,970 $ 1.51  The Company granted a total of 101,250 , 293,500 and 213,576 shares of restricted stock or shares issuable pursuant to promises to issue shares of common stock during the years ended September 30, 2016, 2015, and 2014 , respectively. The stock granted during the year ended September 30, 2016 includes rights to receive a total of 13,498 shares, or at a holder’s election cash based on the fair market value of the shares, contingent on continued employment or service. The fair value of the awards granted was approximately $ 153,000 , $ 499,000 and $ 1,665,000 for the years ended September 30, 2016, 2015, and 2014 , respectively. During the year ended September 30, 2016, holder’s elected to receive cash on a total of 27,666 shares based on the stock price at the time of vesting of $1.32 . All such shares of restricted stock vest and all such shares must be issued pursuant to the vesting period noted, provided the grantee has not voluntarily terminated service or been terminated for cause prior to the vesting or issuance date. There were 0 , 58,250 and 250 shares of restricted stock forfeited during the years ended September 30, 2016, 2015, and 2014 , respectively.  The Company recognized the fair value of the restricted stock or promises to issue shares of common stock that vested during the fiscal year as share-based compensation expense of approximately $ 495,000 , $ 437,000 and $ 859,000 for the years ended September 30, 2016, 2015, and 2014 , respectively, $ 29,000 , $ 23,000 and $ 256,000 of which was included in accrued expenses at year end since the related shares have not yet been issued at September 30, 2016, 2015, and 2014 , respectively. The share-based compensation expense was included in selling, general and administrative expenses for the respective periods. The Company recorded a tax benefit for stock-based compensation expenses of approximately $ 115,000 , $114,000 , and $ 204,000 for the years ended September 30, 2016, 2015, and 2014 , respectively. The Company realized the tax benefit for stock-based compensation expenses, for the shares which vested, of approximately $141,000 , $190,000 and $0 for the years ended September 30, 2016, 2015, and 2014 , respectively. As of September 30, 2016 , there was approximately $ 287,000 , representing approximately 190,000 unvested shares, of total unrecognized compensation cost related to non-vested restricted stock compensation arrangements granted under the incentive plans. This unrecognized cost will be recognized over the weighted average period of the next 1.89 years.  Common Stock Purchase Warrants  The Company did no t issue any common stock purchase warrants in fiscal year 2016, 2015, or 2014 . There is no unrecognized compensation cost related to warrants as of September 30, 2016 .  At September 30, 2016 and 2015 , there were no outstanding warrants.  Preferred Stock  The Company has 5,000,000 shares designated as Class A Preferred Stock with a par value of $.01 per share. There are 1,040,000 shares of Class A Preferred Stock - Series 1 authorized; 1,500,000 shares of Class A Preferred Stock- Series 2 authorized; and 700,000 shares of Class A Preferred Stock - Series 3 authorized. There were no shares of Class A Preferred Stock of any series issued and outstanding in fiscal 2016 or 2015 . T he Company has 15,000 shares designated as Class B Preferred Stock with a par value of $0.50 per share . There were no shares of Class B Preferred Stock issued and outstanding in fiscal 2016 or 2015 .

Stock Repurchase Program

Stock Repurchase Program	12 Months Ended
	Sep. 30, 2016
Stock Repurchase Program [Abstract]
Stock Repurchase Program	Note 8. Stock Repurchase Program  The Company’s Stock Repurchase Program was announced on January 17, 2007. At initiation, the plan’s terms specified that up to 1,000,000 shares of its common stock could be purchased during the subsequent twelve months. Subsequently, the Board has amended the plan a number of times to both extend its term and increase the maximum number of shares which could be repurchased. Currently, the plan allows for a maximum repurchase of up to 3,000,000 shares through the period ending December 31, 201 6 . From the program’s onset through September 30, 2016 , the total number of shares repurchased by the Company is 2,183,704 . The Stock Repurchase Program authorizes purchases in privately negotiated transactions as well as in the open market. In October 2008, the Company's Board of Directors authorized repurchases in private transactions under the Stock Repurchase Program of shares issued under the Company's equity compensation plans to directors, employees and other service providers at the market price on the effective date of the repurchase request. Total repurchases under this provision currently are limited to an aggregate of 450,000 shares per calendar year and to a maximum of 50,000 shares annually per individual. Total repurchase transaction are as follows (in shares):     2016 2015 2014  Open market repurchase transactions - - 165,000  Private repurchase transactions - 250 4,000  Total repurchase transactions - 250 169,000  Total repurchase activity is as follows:      Issuer Purchases of Equity  Securities: Details of Treasury Stock Purchases to Date through September 30, 2016:  Total Average Aggregate Number Maximum Number  Number Price Paid of Shares Purchased of Shares that May  of Shares Per As Part of Publicly Yet be Purchased  Period Purchased Share Announced Program Under the Program  January 1, 2007 – September 30, 2013 2,014,454 3.51 2,014,454 985,546  October 1, 2013 – September 30, 2014 169,000 4.37 2,183,454 816,546  October 1, 2014 – September 30, 2015 250 3.80 2,183,704 816,296  October 1, 2015 – September 30, 2016 — — 2,183,704 816,296  Total 2,183,704 $ 3.57 2,183,704 816,296  

Employee Benefit Plan

Employee Benefit Plan	12 Months Ended
	Sep. 30, 2016
Employee Benefit Plan [Abstract]
Employee Benefit Plan	Note 9. Employee Benefit Plan  The Company has a Simple Individual Retirement Account (IRA) plan for its employees. Employees are eligible to participate in the plan if their compensation reaches certain minimum levels and are allowed to contribute up to a maximum of $15,500 annual compensation to the plan. The Company has elected to match 100 percent of employee contributions to the plan up to a maximum of 3 percent of employee compensation for the years ended September 30, 2016, 2015, and 2014 . Annual Company contributions were approximately $33,000 , $37,000 , and $31,000 for the years ended September 30, 2016, 2015, and 2014 , respectively.  In March 2014, the Company elected to contribute 3 percent into the personal pension schemes of certain senior U.K. employees. Contributions for the years ended September 30, 2016, 2015, and 2014 were approximately $23,000 , $26,000 , and $6,000 , respectively. 

Industry Segments And Financial

Industry Segments And Financial Information About Foreign And Domestic Operations	12 Months Ended
	Sep. 30, 2016
Industry Segments And Financial Information About Foreign And Domestic Operations [Abstract]
Industry Segments And Financial Information About Foreign And Domestic Operations	Note 10. Industry Segments and Financial Information about Foreign and Domestic Operations  The Company currently operates in one industry segment which includes the development, manufacture and marketing of consumer health care products.  The Company operates in foreign and domestic regions. Information about the Company's operations by geographic area is as follows (in thousands).      Net Revenues to External Customers for Long-Lived Asset As Of  the Year Ended September 30, September 30,  2016 2015 2014 2016 2015  Brazil $ 6,008 (1) $ 14,841 (1) $ * $ - $ -  Zimbabwe 3,305 (1) 2,696 2,064 - -  United States 2,464 (1) 2,029 2,381 7,963 123  South Africa 1,117 2,331 2,928 (1) - -  Angola * * 2,477 (1) - -  DR of Congo * * 2,185 - -  Tanzania * * 1,936 - -  Malaysia * * * 796 1,134  United Kingdom * * * 93 120  Other 9,233 10,708 10,520 - -  Total $ 22,127 $ 32,605 $ 24,491 $ 8,852 $ 1,377  * Less than 5 percent of total net revenues. (1) Exceeds 10 percent of total net revenues.

Contingent Liabilities

Contingent Liabilities	12 Months Ended
	Sep. 30, 2016
Contingent Liabilities [Abstract]
Contingent Liabilities	Note 11. Contingent Liabilities The testing, manufacturing and marketing of consumer products by the Company entail an inherent risk that product liability claims will be asserted against the Company. The Company maintains product liability insurance coverage for claims arising from the use of its products. The coverage amount is currently $10 million for FHC's consumer health care product. 

Dividends

Dividends	12 Months Ended
	Sep. 30, 2016
Dividends [Abstract]
Dividends	Note 1 2 . Dividends  Beginning February 16, 2010 through May 7, 2014, the Company paid 18 quarterly cash dividends. The first 9 were paid at a quarterly rate per share of $0.05 through February 9, 2012, 4 were paid at a quarterly rate per share of $0.06 from May 9, 2012 through February 6, 2013, and 5 were paid at a quarterly rate per share of $0.07 from May 8, 2013 through May 7, 2014. C ash dividends paid totaled $29.4 million through September 30, 2014. T he Company paid cash dividends of approximately $6.1 million and $7.5 million in 2014 and 2013, respectively. On July 14, 2014, the Company announced that its Board of Directors elected to suspend the payment of quarterly cash dividends in order to devote operating cash flows towards strategic growth initiatives.

Quarterly Financial Data

Quarterly Financial Data	12 Months Ended
	Sep. 30, 2016
Quarterly Financial Data [Abstract]
Quarterly Financial Data	Note 1 3 . Quarterly Financial Data (Unaudited)      First Second Third Fourth Year  Quarter Quarter Quarter Quarter Ended  2016  Net revenues $ 8,230,659 $ 4,772,801 $ 5,560,776 $ 3,563,106 $ 22,127,342  Gross profit 5,402,337 2,845,395 3,233,193 1,868,559 13,349,484  Operating expenses 3,009,782 2,774,970 2,384,674 2,161,546 10,330,972  Income tax expense (benefit) 829,453 (27,824) 231,211 1,436,351 2,469,191  Net income (loss) 1,490,363 35,045 570,258 (1,750,941) 344,725  Net income (loss) per common share – basic 0.05 — 0.02 (0.06) 0.01  Net income (loss) per common share – diluted 0.05 — 0.02 (0.06) 0.01   2015  Net revenues $ 6,659,206 $ 10,977,467 $ 7,813,207 $ 7,154,985 $ 32,604,865  Gross profit 3,819,673 6,394,107 4,632,535 4,123,644 18,969,959  Operating expenses 2,365,824 3,444,714 3,178,687 3,362,327 12,351,552  Income tax expense 670,430 1,306,445 284,900 79,229 2,341,004  Net income 804,917 1,667,574 1,170,974 702,571 4,346,036  Net income per common share – basic 0.03 0.06 0.04 0.02 0.15  Net income per common share – diluted 0.03 0.06 0.04 0.02 0.15 

Subsequent Events

Subsequent Events	12 Months Ended
	Sep. 30, 2016
Subsequent Events [Abstract]
Subsequent Events	Note 14 . Subsequent Events  On October 31, 2016 , the Company completed a merger transaction (the APP Merger) with Aspen Park Pharmaceuticals, Inc. (APP), pursuant to an Amended and Restated Agreement and Plan of Merger, dated as of October 31, 2016 (the Amended Merger Agreement), among the Company, Blue Hen Acquisition, Inc. and APP. Consummation of the APP Merger did not require the current approval of FHC's shareholders.  Under the terms of the Amended Merger Agreement, the outstanding shares of APP common stock and preferred stock were converted into the right to receive in the aggregate 2,000,000 shares of the Company's common stock and 546,756 shares of the Company's Class A Convertible Preferred Stock - Series 4 (the Series 4 Preferred Stock).  The terms of the Series 4 Preferred Stock include the following: · Each share of Series 4 Preferred Stock will automatically convert into 40 shares of the Company's common stock upon receipt by the Company of approval by the affirmative vote of the Company's shareholders by the required vote under the Wisconsin Business Corporation Law and the NASDAQ listing rules, as applicable, of (i) an amendment to the Company's Amended and Restated Articles of Incorporation to increase the total number of authorized shares of the Company's common stock by a sufficient amount to permit such conversion and (ii) the conversion of the Series 4 Preferred Stock pursuant to applicable NASDAQ rules. · Upon a Liquidation Event, the holders of the Series 4 Preferred Stock will be entitled to a liquidation preference equal to the greater of (a) $1.00 per share (or $546,756 in the aggregate for all of the shares of Series 4 Preferred Stock), or (b) the amount holders would have received if the Series 4 Preferred Stock had converted to the Company's common stock. A "Liquidation Event" includes any voluntary or involuntary liquidation, dissolution or winding up of the Company and certain transactions involving an acquisition of the Company (which are referred to as Fundamental Changes). · T he Series 4 Preferred Stock is redeemable on the first to occur of (i) the 20th anniversary of the date of original issuance or (ii) a Fundamental Change, at a price equal to $1.00 per share, unless converted into the Company's common stock prior to such redemption. · The Series 4 Preferred Stock is senior to all existing and future classes of the Company's capital stock upon a Liquidation Event, and no senior or additional pari passu preferred stock may be issued without the consent of the holders of a majority of the outstanding shares of Series 4 Preferred Stock. · The Series 4 Preferred Stock participates in dividends paid to holders of the Company's common stock on an as converted basis. · The Series 4 Preferred Stock has one vote per share and will generally vote with the Company's common stock on a one share to one share basis  After giving effect to the conversion of the Series 4 Preferred Stock to the Company's common stock, which is wholly dependent upon future shareholder approval as described above, the former APP stockholders will own 23,870,249 shares of the Company's common stock in total, constituting approximately 45% of the outstanding shares of the Company's common stock as of October 31, 2016.  The total estimated purchase price of approximately $22,676,737 is based on the closing price of the Company's common stock of $0.95 per share on October 31, 2016 and the issuance to the APP stockholders of a total of 23,870,249 shares of the Company's common stock (assuming conversion of the Series 4 Preferred Stock).  The Company is currently in the process of determining the fair value of the assets acquired and liabilities assumed in the business combination.  The amounts of pro forma, unaudited net revenues and net income (loss) of the combined entity had the acquisition date been October 1, 2013 are as follows:     Period Net revenues Net income (loss)  October 1, 2013 - September 30, 2014* $ 24,490,586 $ 2,388,785  October 1, 2014 – September 30, 2015 $ 32,621,548 $ 3,028,101  October 1, 2015 – September 30, 2016 $ 22,143,411 $ (2,434,976) * Includes the results for APP from the date of inception, June 9, 2014 through September 30, 2014.  In connection with the closing of the APP Merger, the Company issued a warrant to purchase up to 2,585,379 shares of the Company's common stock to Torreya Capital, the Company's financial advisor (the Financial Advisor Warrant). The Financial Advisor Warrant has a five -year term, a cashless exercise feature and a strike price equal to $1.93 per share, the average price of the Company's common stock for the ten-day period preceding the original announcement of the APP Merger on April 6, 2016. The fair value of the Financial Advisor Warrant is $723,906 based on the average closing price of the Company's common stock for the five days prior to October 31, 2016 of $1.02 . The Financial Advisor Warrant was vested upon issuance.  In connection with the closing of the APP Merger, vesting was accelerated as to restricted stock and other stock awards covering a total of 221,549 shares held by certain members of the Company's board of directors and certain employees. The fair value of these awards is $210,472 based on the closing price of the Company’s common stock on October 31, 2016 of $0.95 .  In connection with the closing of the APP Merger, the Company issued stock awards covering a total of 760,000 shares to a member of the Company's board of directors and a consultant. One -half of these stock awards consist of restricted stock and stock options which vest on the first anniversary of the grant date and the other half of these stock awards consist of restricted stock units and stock appreciation rights that vest on the second anniversary of the grant date. The restricted stock units and stock appreciation rights will be settled in the Company's common stock if, prior to the vesting date, the Company receives shareholder approval under the NASDAQ listing rules to (i) increase the number of authorized shares under the 2008 Stock Incentive Plan sufficient to issue such shares or (ii) adopt a new plan under which such shares would be issued. If such approval is not received by the vesting date, such awards will be settled in cash based on the fair market value of the Company's common stock on the vesting date in the case of the restricted stock units and on the exercise date in the case of the stock appreciation rights. The fair value of these awards is approximately $722,000 and they have a weighted average life of 5.75 years.  APP signed a lease for approximately 2,600 sq. ft. of office space in Miami, Florida with an effective date of November 1, 2016 and a three -year term ending November 1, 2019, with two renewal options for the Company to extend the term for a period of three years each. The lease requires monthly payments of $9,240 , with a 4% annual increase, plus sales taxes.  In connection with the APP Merger, two complaints have been filed against the Company and its directors alleging breach of fiduciary duty and/or wasting of corporate assets. The Company intends to vigorously defend these lawsuits.

Nature Of Business And Signif22

Nature Of Business And Significant Accounting Policies (Policy)	12 Months Ended
	Sep. 30, 2016
Nature Of Business And Significant Accounting Policies [Abstract]
Principles Of Consolidation And Nature Of Operations	Principles of consolidation and nature of operations : The consolidated financial statements include the accounts of The Female Health Company (FHC or the Company) and its wholly owned subsidiary, The Female Health Company – UK, and its wholly owned subsidiaries, The Female Health Company - UK, plc and The Female Health Company (M) SDN.BHD. All significant intercompany transactions and accounts have been eliminated in consolidation. Prior to t he completion of the merger transaction with APP (see note 14), t he Company had been a single product company engaged in the marketing, manufacture and distribution of a consumer health care product, the FC2 female condom (FC2). The Female Health Company - UK, is the holding company of The Female Health Company - UK, plc, which is located in a 6,400 sq. ft. leased office facility located in London, England (collectively the U.K. subsidiary). The Female Health Company (M) SDN.BHD leases a 45,800 sq. ft. manufacturing facility located in Selangor D.E., Malaysia (the Malaysia subsidiary).  FC2 has been distributed in either or both commercial (private sector) and public health sector markets in 144 countries. It is marketed to consumers through distributors, public health programs and retailers in 16 countries.  The Company's standard credit terms vary from 30 to 120 days, depending on the class of trade and customary terms within a territory, so accounts receivable is affected by the mix of purchasers within the period. As is typical in the Company's business, extended credit terms may occasionally be offered as a sales promotion or for certain sales. The Company has agreed to credit terms of up to 150 days with our distributor in the Republic of South Africa. For the most recent order of 15 million units under the Brazil tender, the Company has agreed to up to 360 day credit terms with our distributor in Brazil subject to earlier payment upon receipt of payment by the distributor from the Brazilian Government. For the past twelve months, the Company's average days’ sales outstanding was approximately 304 days. Over the past five years, the Company’s bad debt expense has been less than 0.02 percent of product sales.
Use Of Estimates	Use of estimates : The preparation of financial statements requires management to make estimates and use assumptions that affect certain reported amounts and disclosures. Significant accounting estimates include the deferred income tax valuation allowance and the value of share-based compensation. Actual results may differ from those estimates.
Cash Concentration	Cash concentration : The Company’s cash is maintained primarily in three financial institutions, located in Chicago, Illinois, London, England and Kuala Lumpur, Malaysia, respectively.
Accounts Receivable And Concentration Of Credit Risk	Accounts receivable and concentration of credit risk : Accounts receivable are carried at original invoice amount less an estimate made for doubtful receivables based on a review of all outstanding amounts on a periodic basis. The components of accounts receivable consist of the following at September 30, 2016 and 2015 :     2016 2015   Trade receivables $ 18,616,342 $ 13,975,905  Other receivables 34,461 160,553  Accounts receivable, gross 18,650,803 14,136,458  Less: allowance for doubtful accounts (38,103) (48,068)  Accounts receivable, net 18,612,700 14,088,390  Less: long-term trade receivables (7,837,500) —  Current accounts receivable, net $ 10,775,200 $ 14,088,390  The Company has long-term trade receivables that may not be collectable within one year of the balance sheet date based on the credit terms with our Brazil distributor.  The Company maintains an allowance for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments on accounts receivable. Management determines the allowance for doubtful accounts by identifying troubled accounts and by using historical experience applied to an aging of accounts. Management also periodically evaluates individual customer receivables and considers a customer’s financial condition, credit history, and the current economic conditions. Accounts receivable are written-off when deemed uncollectible. The table below sets forth the components of the allowance for doubtful accounts for the years ended September 30:      Balance at Provision Charges Write offs/ Balance at  Year October 1 to Expenses Recoveries September 30  2014 $ 13,180 $ 38,068 $ (3,180) $ 48,068  2015 $ 48,068 $ — $ — $ 48,068  2016 $ 48,068 $ — $ (9,965) $ 38,103 R ecoveries of accounts receivable previously written-off are recorded when received. The Company’s customers are primarily large global agencies, non-government organizations, ministries of health and other governmental agencies which purchase and distribute the female condom for use in HIV/AIDS prevention and family planning programs. In fiscal year 2016 and fiscal year 2015, our significant customers were Semina Indústria e Comércio Ltda (Semina), United Nations Population Fund (UNFPA), and the United States Agency for International Development (USAID). In fiscal year 2014, our significant customers were UNFPA, USAID, Sekunjalo Investments Corporation (PTY) Ltd (Sekunjalo), and Azinor International Lda (Azinor). No other single customer accounted for more than 10 percent of unit sales during those periods.      Percentage of Unit Sales  Significant Customers 2016 2015 2014  Semina 27% 47% *  UNFPA 25% 18% 40%  USAID 24% 16% 17%  Sekunjalo * * 13%  Azinor * * 11%  Total Percentage of Unit Sales 76% 81% 81% _____________________  * Less than 10 percent of unit sales.  Semina’s current accounts receivable balance represented 44 percent and 46 percent of current assets at September 30, 2016 and 2015, respectively. No other single customer’s accounts receivable balance accounted for more than 10 percent of current assets at the end of those periods. Semina’s total accounts receivable balance represented 85 percent and 71 percent of trade receivables at September 30, 2016 and 2015, respectively.
Inventory	Inventory : Inventories are valued at the lower of cost or market. The cost is determined using the first-in, first-out (FIFO) method. Inventories are also written down for management’s estimates of product which will not sell prior to its expiration date. Write-downs of inventories establish a new cost basis which is not increased for future increases in the market value of inventories or changes in estimated obsolescence.
Foreign Currency and Change in Functional Currency	Foreign currency translation and operations : Effective October 1, 2009, the Company determined that there were significant changes in facts and circumstances, triggering an evaluation of its subsidiaries’ functional currency. The evaluation indicated that the U.S. dollar is the currency with the most significant influence upon the subsidiaries. Because all of the U.K. subsidiary's future sales and cash flows would be denominated in U.S. dollars following the October 2009 cessation of production of the Company’s first generation product, FC1, the U.K. subsidiary adopted the U.S. dollar as its functional currency effective October 1, 2009. As the Malaysia subsidiary is a direct and integral component of the U.K. parent’s operations, it, too, adopted the U.S. dollar as its functional currency as of October 1, 2009. The consistent use of the U.S. dollar as functional currency across the Company reduces its foreign currency risk and stabilizes its operating results. The Company recognized a foreign currency transaction loss of $ 147,540 , a foreign currency transaction gain of $ 58,483 , and a foreign currency transaction loss of $ 83,844 for the years ended September 30, 2016, 2015, and 2014 , respectively. The cumulative foreign currency translation loss included in accumulated other comprehensive loss was $581,519 as of September 30, 2016 and 2015 . Assets located outside of the U.S. totaled approximately $5,500,000 and $10,000,000 at September 30, 2016 and 2015 , respectively.
Equipment, Furniture And Fixtures	Equipment, furniture and fixtures : Depreciation and amortization are computed using primarily the straight-line method. Depreciation and amortization are computed over the estimated useful lives of the respective assets which range as follows:      Manufacturing equipment 5 – 10 years  Office equipment 3 – 5 years  Furniture and fixtures 7 – 10 years  Depreciation on leased assets is computed over the lesser of the remaining lease term or the estimated useful lives of the assets. Depreciation on leased assets is included with depreciation on owned assets.
Patents And Trademarks	Patents and trademarks : The costs for patents and trademarks are expensed when incurred. FC2 patents have been issued by the United States, Europe, Canada, Australia, South Africa, the People’s Republic of China, Japan, Mexico, Brazil, India and the African Regional Intellectual Property Organization (ARIPO), which includes Botswana, Gambia, Ghana, Kenya, Lesotho, Malawi, Mozambique, Namibia, Sierra Leone, Sudan, Swaziland, Tanzania, Uganda, Zambia, and Zimbabwe. Further, the European patent for FC2 has been validated in the following countries: Austria, Belgium, Bulgaria, Switzerland, Republic of Cyprus, Czech Republic, Germany, Denmark, Estonia, Spain, Finland, France, United Kingdom, Greece, Hungary, Ireland, Italy, Luxembourg, Monaco, Netherlands, Portugal, Romania, Sweden, Slovenia, Slovakia, and Turkey. The patents cover the key aspects of FC2, including its overall design and manufacturing process. The patents have expiration dates in 2023 and 2024.  The Company has a registration for the trademark “FC2 Female Condom” in the United States. Furthermore, the Company has filed applications or secured registrations in 40 countries or jurisdictions around the world to protect the various names and symbols used in marketing its Female Condoms. In addition, the experience that has been gained through years of manufacturing its Female Condoms (FC1 and FC2) has allowed the Company to develop trade secrets and know-how, including certain proprietary production technologies, that further protect its competitive position.
Financial Instruments	Financial instruments : The Company follows ASC Topic 820, Fair Value Measurements and Disclosures , which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. The fair value framework requires the categorization of assets and liabilities into three levels based upon the assumptions (inputs) used to price the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment.  The Company currently does not have any assets or liabilities measured at fair value on a recurring or non-recurring basis. Substantially all of the Company’s cash, as well as restricted cash, are held in demand deposits with three financial institutions. The Company has no financial instruments for which the carrying value is materially different than fair value.
Research And Development Costs	Research and development costs : Research and development costs are expensed as incurred. The amount of costs expensed for the years ended September 30, 2016, 2015, and 2014 were $99,393 , $219,815 , and $5,575 , respectively.
Restricted Cash	Restricted cash : Restricted cash relates to security provided to one of the Company’s U.K. banks for performance bonds issued in favor of customers. The Company has a facility of $250,000 for such performance bonds. Such security has been extended infrequently and only on occasions where it has been a contract term expressly stipulated as an absolute requirement by the customer or its provider of funds. The expiration of the bond is defined by the completion of the event such as, but not limited to, a period of time after the product has been distributed or expiration of the product shelf life. Restricted cash was $ 134,443 and $ 85,697 for the years ended September 30, 2016 and 2015 , respectively, and is included in cash on the accompanying balance sheets.
Revenue Recognition	Revenue recognition : The Company recognizes revenue from product sales when each of the following conditions has been met: an arrangement exists, delivery has occurred, there is a fixed price, and collectability is reasonably assured.
Share-based Compensation	Share-based compensation : The Company accounts for stock-based compensation expense for equity awards exchanged for services over the vesting period based on the grant-date fair value. In many instances, the equity awards are issued upon the grant date subject to vesting periods. In certain instances, the equity awards provide for future issuance contingent on future continued employment or performance of services as of the issuance date.
Advertising	Advertising : The Company's policy is to expense advertising costs as incurred. Advertising costs were $ 88,866 , $0 , and $ 58,121 for the years ended September 30, 2016, 2015, and 2014 , respectively.
Income Taxes	Income taxes : The Company files separate income tax returns for its foreign subsidiaries. ASC Topic 740 requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial statements and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Deferred tax assets are also provided for carryforwards for income tax purposes. In addition, the amount of any future tax benefits is reduced by a valuation allowance to the extent such benefits are not expected to be realized.
Earnings Per Share (EPS)	Earnings per share (EPS) : Basic EPS is computed by dividing net income by the weighted average number of common shares outstanding for the period. Diluted EPS is computed by dividing net income by the weighted average number of common shares outstanding during the period after giving effect to all dilutive potential common shares that were outstanding during the period. Dilutive potential common shares consist of the incremental common shares issuable upon the exercise of stock options and unvested shares granted to employees and directors.
Other Comprehensive Income	Other comprehensive income : Accounting principles generally require that recognized revenue, expenses, gains and losses be included in net income. Although certain changes in assets and liabilities, such as foreign currency translation adjustments, are reported as a separate component of the equity section of the accompanying consolidated balance sheets, these items, along with net income, are components of comprehensive income.  The U.S. parent company and its U.K. subsidiary routinely purchase inventory produced by its Malaysia subsidiary for sale to their respective customers. These intercompany trade accounts are eliminated in consolidation. The Company’s policy and intent is to settle the intercompany trade account on a current basis. Since the U.K. and Malaysia subsidiaries adopted the U.S. dollar as their functional currencies effective October 1, 2009, no foreign currency gains or losses from intercompany trade are recognized. In fiscal 2016, 2015, and 2014 , comprehensive income is equivalent to the reported net income.
Recently issued accounting pronouncements	Recently issued accounting pronouncements : In November 2015, the Financial Accounting Standards Board (FASB) issued ASU 2015-17, Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes. The amendments in this Update require that deferred tax liabilities and assets be classified as non-current in a classified statement of financial position. Current accounting principles require an entity to separate deferred income tax liabilities and assets into current and non-current amounts in a classified statement of financial position. ASU 2015-17 will be effective for the Company beginning on October 1, 2017.  In May 2014, the FASB issued ASU 2014-09 “Revenue from Contracts with Customers” (Topic 606). This new accounting guidance on revenue recognition provides for a single five-step model to be applied to all revenue contracts with customers. The new standard also requires additional financial statement disclosures that will enable users to understand the nature, amount, timing and uncertainty of revenue and cash flows relating to customer contracts. ASU 2014-09 will be effective for the Company beginning on October 1, 2018. We are currently evaluating the impact of the new guidance on our consolidated financial statements and have not yet selected a transition approach to implement the standard.  In July 2015, the FASB issued ASU 2015-11, Inventory (Topic 330): Simplifying the Measurement of Inventory. This new accounting guidance more clearly articulates the requirements for the measurement and disclosure of inventory. Topic 330, Inventory, currently requires an entity to measure inventory at the lower of cost or market. Market could be replacement cost, net realizable value, or net realizable value less an approximately normal profit margin. This new accounting guidance requires the measurement of inventory at the lower of cost or net realizable value. ASU 2015-11 will be effective for the Company beginning on October 1, 2017. The adoption of this guidance is not expected to have a material impact on our consolidated financial statements.  In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). The amendments in this Update increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. ASU 2016-02 will be effective for the Company beginning on October 1, 2019. We are currently evaluating the impact of the new guidance on our consolidated financial statements and have not yet selected a transition approach to implement the standard.  In March 2016, the FASB issued ASU 2016-09, Compensation – Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting. The amendments in this Update simplify the income tax effects, minimum statutory tax withholding requirements and impact of forfeitures related to how share-based payments are accounted for and presented in the financial statements. ASU 2016-09 will be effective for the Company beginning on October 1, 2017. We are currently evaluating the impact of the new guidance on our consolidated financial statements and have not yet selected a transition approach to implement the standard.

Nature Of Business And Signif23

Nature Of Business And Significant Accounting Policies (Tables)	12 Months Ended
	Sep. 30, 2016
Nature Of Business And Significant Accounting Policies [Abstract]
Components Of Accounts Receivable	   2016 2015   Trade receivables $ 18,616,342 $ 13,975,905  Other receivables 34,461 160,553  Accounts receivable, gross 18,650,803 14,136,458  Less: allowance for doubtful accounts (38,103) (48,068)  Accounts receivable, net 18,612,700 14,088,390  Less: long-term trade receivables (7,837,500) —  Current accounts receivable, net $ 10,775,200 $ 14,088,390 
Summary Of Components Of Allowance For Doubtful Accounts	   Balance at Provision Charges Write offs/ Balance at  Year October 1 to Expenses Recoveries September 30  2014 $ 13,180 $ 38,068 $ (3,180) $ 48,068  2015 $ 48,068 $ — $ — $ 48,068  2016 $ 48,068 $ — $ (9,965) $ 38,103 
Summary Of Significant Customers	   Percentage of Unit Sales  Significant Customers 2016 2015 2014  Semina 27% 47% *  UNFPA 25% 18% 40%  USAID 24% 16% 17%  Sekunjalo * * 13%  Azinor * * 11%  Total Percentage of Unit Sales 76% 81% 81% _____________________  * Less than 10 percent of unit sales.
Summary Of Depreciation And Amortization	   Manufacturing equipment 5 – 10 years  Office equipment 3 – 5 years  Furniture and fixtures 7 – 10 years 

Earnings Per Share (Tables)

Earnings Per Share (Tables)	12 Months Ended
	Sep. 30, 2016
Earnings Per Share [Abstract]
Schedule Of Earnings Per Share, Basic And Diluted	   Year Ended September 30,  Denominator 2016 2015 2014  Weighted average common shares outstanding - basic 28,666,477 28,532,327 28,522,525  Net effect of dilutive securities:  Options 11,443 50,473 109,583  Unvested restricted shares 248,637 334,248 233,276  Total net effect of dilutive securities 260,080 384,721 342,859  Weighted average common shares outstanding - diluted 28,926,557 28,917,048 28,865,384  Income per common share – basic $ 0.01 $ 0.15 $ 0.09  Income per common share – diluted $ 0.01 $ 0.15 $ 0.08 

Inventory (Tables)

Inventory (Tables)	12 Months Ended
	Sep. 30, 2016
Inventory [Abstract]
Components Of Inventory	   2016 2015   Raw material $ 670,802 $ 839,179  Work in process — 77,483  Finished goods 1,834,958 868,270  Inventory, gross 2,505,760 1,784,932  Less: inventory reserves (13,116) (39,752)  Inventory, net $ 2,492,644 $ 1,745,180 
Change In Inventory Reserve	   Balance at Charged to Costs Balance at  Year October 1 and Expenses Write-offs September 30  2014 $ 41,133 $ 37,603 $ (17,863) $ 60,873  2015 $ 60,873 $ 173,634 $ (194,755) $ 39,752  2016 $ 39,752 $ (8,630) $ (18,006) $ 13,116 

Operating Leases And Rental E26

Operating Leases And Rental Expense (Tables)	12 Months Ended
	Sep. 30, 2016
Operating Leases And Rental Expense [Abstract]
Schedule Of Operating Lease Expense, Including Real Estate Taxes And Insurance	   2016 2015 2014  Factory and office leases $ 455,956 $ 470,049 $ 439,722  Other 15,176 7,387 4,758  Total $ 471,132 $ 477,436 $ 444,480 
Schedule Of Future Minimum Payments Under Leases	   Operating  Leases  2017 $ 345,301  2018 401,624  2019 401,904  2020 186,305  2021 110,803  Thereafter 228,298  Total minimum lease payments $ 1,674,235 

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Sep. 30, 2016
Income Taxes [Abstract]
Schedule Of Income Before Income Taxes, By Jurisdictions	   2016 2015 2014  Domestic $ 1,068,580 $ 4,524,499 $ 2,837,835  Foreign 1,745,336 2,162,541 1,119,356  Total $ 2,813,916 $ 6,687,040 $ 3,957,191 
Reconciliation Of Income Tax Expense (Benefit)	   2016 2015 2014  Income tax expense at statutory rates $ 957,000 $ 2,274,000 $ 1,345,000  State income tax, net of federal benefits 149,000 362,000 248,000  Non-deductible expenses - other 50,000 51,000 (5,000)  Non-deductible business acquisition expenses 556,000 — —  Effect of lower foreign income tax rates (305,648) (351,244) (175,632)  Effect of change in U.K. tax rate 1,251,000 — —  Effect of reinvestment allowance - Malaysia — — (9,000)  Effect of export allowance - Malaysia — (85,000) —  Effect of change in Illinois tax rate — 202,000 —  Effect of conversion of charitable contribution to NOL — (36,174) —  Other 87,839 (59,578) 56,762  Change in valuation allowance (18,000) (16,000) 64,000  Effect of UK tax rate change on valuation allowance (258,000) — —  Income tax expense $ 2,469,191 $ 2,341,004 $ 1,524,130 
Summary Of Federal And State Income Tax Provision (Benefit)	   2016 2015 2014  Deferred – U.S. $ 881,000 $ 1,856,000 $ 561,000  Deferred – U.K. 1,162,000 162,000 496,000  Deferred – Malaysia 11,817 (92,261) (44,666)  Subtotal 2,054,817 1,925,739 1,012,334  Current – U.S. 104,000 83,606 219,000  Current – Malaysia 310,374 331,659 292,796  Current - U.K. — — —  Subtotal 414,374 415,265 511,796  Income tax expense $ 2,469,191 $ 2,341,004 $ 1,524,130 
Significant Components Of Deferred Tax Assets And Liabilities	   Deferred Tax Assets 2016 2015  Federal net operating loss carryforwards $ 2,756,000 $ 4,428,000  State net operating loss carryforwards 400,000 644,000  AMT credit carryforward 489,000 390,000  Foreign net operating loss carryforwards – U.K. 10,955,000 12,388,000  Foreign capital allowance – U.K. 112,000 114,000  Other, net - Malaysia 9,850 13,097  Restricted stock – U.K. 1,000 —  Share-based compensation 101,000 128,000  Deemed dividend - Malaysia 942,000 —  Other, net - U.S. 25,000 8,000  Gross deferred tax assets 15,790,850 18,113,097  Valuation allowance for deferred tax assets (2,299,000) (2,575,000)  Net deferred tax assets 13,491,850 15,538,097  Deferred Tax Liabilities:  Foreign capital allowance – Malaysia (119,919) (111,349)  Net deferred tax assets $ 13,371,931 $ 15,426,748 
Schedule Of Deferred Tax Amounts Classified In Balance Sheets	   2016 2015  Current assets – U.S. $ 2,020,000 $ 854,000  Current assets – U.K. 5,000 162,000  Total current assets 2,025,000 1,016,000  Long-term assets – U.S. 2,693,000 4,740,000  Long-term assets – U.K 8,764,000 9,769,000  Total long-term assets 11,457,000 14,509,000  Long-term liability – Malaysia (110,069) (98,252)  $ 13,371,931 $ 15,426,748 
Changes In Valuation Allowance For Deferred Tax Assets	   Balance at Charged to Costs Balance at  Year October 1 and Expenses Deductions/Other September 30  2014 $ 2,147,000 $ 432,000 $ 12,000 $ 2,591,000  2015 $ 2,591,000 $ (16,000) $ — $ 2,575,000  2016 $ 2,575,000 $ (276,000) $ — $ 2,299,000 

Equity And Share-Based Paymen28

Equity And Share-Based Payments (Tables)	12 Months Ended
	Sep. 30, 2016
Equity And Share-Based Payments [Abstract]
Weighted Average Assumptions For Options Granted	   Expected Volatility 43.19%  Expected Dividend Yield 0.00%  Risk-free Interest Rate 1.53%  Expected Term (in years) 6  Fair Value of Options Granted $ 0.78 
Summary Of Stock Options Outstanding And Exercisable	   Weighted Average  Remaining Aggregate  Exercise Price Contractual Term Intrinsic  Shares Per Share (years) Value  Outstanding at September 30, 2013 240,000 $ 2.64  Granted — —  Exercised (60,000) 2.79  Forfeited — —  Outstanding at September 30, 2014 180,000 $ 2.60  Granted — —  Exercised — —  Forfeited — —  Outstanding at September 30, 2015 180,000 $ 2.60  Granted 17,500 1.82  Exercised — —  Forfeited — —  Outstanding at September 30, 2016 197,500 $ 2.53 2.06 $ —  Exercisable on September 30, 2016 180,000 $ 2.60 1.34 $ — 
Summary Of Non-Vested Stock Activity	   Weighted Average  Grant -Date  Shares Fair Value Vesting Period  Total Outstanding September 30, 2013 33,502 $ 6.80  Stock Granted 213,576 7.80 September 2014 - December 2016  Vested (105,393) 8.15  Forfeited (250) 9.68  Total Outstanding September 30, 2014 141,435 $ 7.30  Stock Granted 293,500 1.70 September 2015 - August 2018  Vested (92,963) 4.70  Forfeited (58,250) 7.36  Total Outstanding September 30, 2015 283,722 $ 2.31  Stock Granted 101,250 1.52 September 2016 - January 2019  Vested (167,336) 2.73  Forfeited — —  Cash Election (27,666) 1.58  Total Outstanding September 30, 2016 189,970 $ 1.51 

Stock Repurchase Program (Table

Stock Repurchase Program (Tables)	12 Months Ended
	Sep. 30, 2016
Stock Repurchase Program [Abstract]
Total Repurchase Transactions	  2016 2015 2014  Open market repurchase transactions - - 165,000  Private repurchase transactions - 250 4,000  Total repurchase transactions - 250 169,000 
Schedule Of Repurchase Activity	   Issuer Purchases of Equity  Securities: Details of Treasury Stock Purchases to Date through September 30, 2016:  Total Average Aggregate Number Maximum Number  Number Price Paid of Shares Purchased of Shares that May  of Shares Per As Part of Publicly Yet be Purchased  Period Purchased Share Announced Program Under the Program  January 1, 2007 – September 30, 2013 2,014,454 3.51 2,014,454 985,546  October 1, 2013 – September 30, 2014 169,000 4.37 2,183,454 816,546  October 1, 2014 – September 30, 2015 250 3.80 2,183,704 816,296  October 1, 2015 – September 30, 2016 — — 2,183,704 816,296  Total 2,183,704 $ 3.57 2,183,704 816,296 

Industry Segments And Financi30

Industry Segments And Financial Information About Foreign And Domestic Operations (Tables)	12 Months Ended
	Sep. 30, 2016
Industry Segments And Financial Information About Foreign And Domestic Operations [Abstract]
Schedule Of Operations By Geographic Area	 Net Revenues to External Customers for Long-Lived Asset As Of  the Year Ended September 30, September 30,  2016 2015 2014 2016 2015  Brazil $ 6,008 (1) $ 14,841 (1) $ * $ - $ -  Zimbabwe 3,305 (1) 2,696 2,064 - -  United States 2,464 (1) 2,029 2,381 7,963 123  South Africa 1,117 2,331 2,928 (1) - -  Angola * * 2,477 (1) - -  DR of Congo * * 2,185 - -  Tanzania * * 1,936 - -  Malaysia * * * 796 1,134  United Kingdom * * * 93 120  Other 9,233 10,708 10,520 - -  Total $ 22,127 $ 32,605 $ 24,491 $ 8,852 $ 1,377  * Less than 5 percent of total net revenues. (1) Exceeds 10 percent of total net revenues.

Quarterly Financial Data (Table

Quarterly Financial Data (Tables)	12 Months Ended
	Sep. 30, 2016
Quarterly Financial Data [Abstract]
Schedule Of Quarterly Financial Data	   First Second Third Fourth Year  Quarter Quarter Quarter Quarter Ended  2016  Net revenues $ 8,230,659 $ 4,772,801 $ 5,560,776 $ 3,563,106 $ 22,127,342  Gross profit 5,402,337 2,845,395 3,233,193 1,868,559 13,349,484  Operating expenses 3,009,782 2,774,970 2,384,674 2,161,546 10,330,972  Income tax expense (benefit) 829,453 (27,824) 231,211 1,436,351 2,469,191  Net income (loss) 1,490,363 35,045 570,258 (1,750,941) 344,725  Net income (loss) per common share – basic 0.05 — 0.02 (0.06) 0.01  Net income (loss) per common share – diluted 0.05 — 0.02 (0.06) 0.01   2015  Net revenues $ 6,659,206 $ 10,977,467 $ 7,813,207 $ 7,154,985 $ 32,604,865  Gross profit 3,819,673 6,394,107 4,632,535 4,123,644 18,969,959  Operating expenses 2,365,824 3,444,714 3,178,687 3,362,327 12,351,552  Income tax expense 670,430 1,306,445 284,900 79,229 2,341,004  Net income 804,917 1,667,574 1,170,974 702,571 4,346,036  Net income per common share – basic 0.03 0.06 0.04 0.02 0.15  Net income per common share – diluted 0.03 0.06 0.04 0.02 0.15 

Subsequent Events (Tables)

Subsequent Events (Tables)	12 Months Ended
	Sep. 30, 2016
Subsequent Events [Abstract]
Schedule of Pro forma of Combined Entity	  Period Net revenues Net income (loss)  October 1, 2013 - September 30, 2014* $ 24,490,586 $ 2,388,785  October 1, 2014 – September 30, 2015 $ 32,621,548 $ 3,028,101  October 1, 2015 – September 30, 2016 $ 22,143,411 $ (2,434,976) * Includes the results for APP from the date of inception, June 9, 2014 through September 30, 2014.

Nature Of Business And Signif33

Nature Of Business And Significant Accounting Policies (Narrative) (Details)	12 Months Ended
	Sep. 30, 2016USD ($)ft²countryitem	Sep. 30, 2015USD ($)	Sep. 30, 2014USD ($)	Sep. 30, 2013USD ($)
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Line Items]
Number of countries in which entity operates | country	144
Number of Countries that have filed applications or secured registrations | country	40
Number of Primary Financial Institutions Where Cash is Maintained | item	3
Average days sales outstanding	304 days
Allowance for Doubtful Accounts Receivable, Current	$ 38,103	$ 48,068	$ 48,068	$ 13,180
Period of which bad debts expense has been a certain percentage of sales	5 years
Advertising	$ 88,866	0	58,121
Restricted cash and cash equivalents, current	134,443	85,697
Foreign currency transaction (loss) gain	(147,540)	58,483	(83,844)
Other comprehensive income (loss), foreign currency transaction and translation gain (loss) arising during period, net of tax	(581,519)	(581,519)
Research and development expense	99,393	219,815	$ 5,575
Performance Bond [Member]
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Line Items]
Restricted cash and cash equivalents, current	250,000
Outside United States [Member]
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Line Items]
Other assets	$ 5,500,000	$ 10,000,000
London, England [Member]
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Line Items]
Area of real estate property | ft²	6,400
Selangor D.E., Malaysia [Member]
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Line Items]
Area of real estate property | ft²	45,800
South Africa [Member]
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Line Items]
Credit terms	150 days
Brazil [Member]
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Line Items]
Number of units ordered | item	15,000,000
Credit terms	360 days
Office Space [Member] | London, England [Member]
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Line Items]
Area of real estate property | ft²	6,400
Manufacturing Space [Member] | Selangor D.E., Malaysia [Member]
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Line Items]
Area of real estate property | ft²	45,800
Minimum [Member]
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Line Items]
Credit terms	30 days
Maximum [Member]
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Line Items]
Credit terms	120 days
Bad debt expense, percentage	0.02%
Country Specific Commercial Partners [Member]
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Line Items]
Number of countries in which entity marketed directly to consumers | country	16
Intercompany Trade Accounts [Member]
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Line Items]
Foreign currency transaction (loss) gain	$ 0

Nature Of Business And Signif34

Nature Of Business And Significant Accounting Policies (Components Of Accounts Receivable) (Details) - USD ($)	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable, gross	$ 18,650,803	$ 14,136,458
Less: allowance for doubtful accounts	(38,103)	(48,068)	$ (48,068)	$ (13,180)
Accounts receivable, net	18,612,700	14,088,390
Less: long-term trade receivables	(7,837,500)
Current accounts receivable, net	10,775,200	14,088,390
Trade Receivables [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable, gross	18,616,342	13,975,905
Other Receivables [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable, gross	$ 34,461	$ 160,553

Nature Of Business And Signif35

Nature Of Business And Significant Accounting Policies (Summary Of Components Of Allowance For Doubtful Accounts) (Details) - USD ($)	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
Nature Of Business And Significant Accounting Policies [Abstract]
Balance at October 1	$ 48,068	$ 48,068	$ 13,180
Provision Charges to Expenses			38,068
Write offs/Recoveries	(9,965)		(3,180)
Balance at September 30	$ 38,103	$ 48,068	$ 48,068

Nature Of Business And Signif36

Nature Of Business And Significant Accounting Policies (Summary Of Significant Customers) (Details)		12 Months Ended
		Sep. 30, 2016	Sep. 30, 2015		Sep. 30, 2014
Total Revenue [Member] | Customer Concentration Risk [Member]
Revenue, Major Customer [Line Items]
Concentration risk, percentage		76.00%	81.00%		81.00%
Total Revenue [Member] | Semina [Member] | Customer Concentration Risk [Member]
Revenue, Major Customer [Line Items]
Concentration risk, percentage		27.00%	47.00%			[1]
Total Revenue [Member] | UNFPA [Member] | Customer Concentration Risk [Member]
Revenue, Major Customer [Line Items]
Concentration risk, percentage		25.00%	18.00%		40.00%	[1]
Total Revenue [Member] | USAID [Member] | Customer Concentration Risk [Member]
Revenue, Major Customer [Line Items]
Concentration risk, percentage		24.00%	16.00%		17.00%	[1]
Total Revenue [Member] | Sekunjalo Investments Corp [Member] | Customer Concentration Risk [Member]
Revenue, Major Customer [Line Items]
Concentration risk, percentage	[1]				13.00%
Total Revenue [Member] | Azinor International Lda [Member] | Customer Concentration Risk [Member]
Revenue, Major Customer [Line Items]
Concentration risk, percentage				[1]	11.00%
Total Revenue [Member] | Less Than 10 Percent Of Unit Sales [Member]
Revenue, Major Customer [Line Items]
Concentration risk, percentage		10.00%
Current Assets [Member] | Customer Concentration Risk [Member]
Revenue, Major Customer [Line Items]
Concentration risk, percentage		44.00%
Current Assets [Member] | More than 10 Percent of Unit Sales [Member] | Customer Concentration Risk [Member]
Revenue, Major Customer [Line Items]
Concentration risk, percentage		10.00%	10.00%
Accounts Receivable [Member] | Semina [Member] | Customer Concentration Risk [Member]
Revenue, Major Customer [Line Items]
Concentration risk, percentage		85.00%	71.00%
[1]	Less than 10 percent of unit sales.

Nature Of Business And Signif37

Nature Of Business And Significant Accounting Policies (Summary Of Depreciation And Amortization) (Details)	12 Months Ended
	Sep. 30, 2016
Minimum [Member] | Manufacturing Equipment [Member]
Property, Plant and Equipment [Line Items]
Useful lives	5 years
Minimum [Member] | Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Useful lives	3 years
Minimum [Member] | Furniture And Fixtures [Member]
Property, Plant and Equipment [Line Items]
Useful lives	7 years
Maximum [Member] | Manufacturing Equipment [Member]
Property, Plant and Equipment [Line Items]
Useful lives	10 years
Maximum [Member] | Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Useful lives	5 years
Maximum [Member] | Furniture And Fixtures [Member]
Property, Plant and Equipment [Line Items]
Useful lives	10 years

Earnings Per Share (Schedule Of

Earnings Per Share (Schedule Of Earnings Per Share, Basic And Diluted) (Details) - $ / shares	3 Months Ended							12 Months Ended
	Sep. 30, 2016	Jun. 30, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013
Schedule of Earnings Per Share, Basic and Diluted [Line Items]
Weighted average common shares outstanding - basic								28,666,477	28,532,327	28,522,525
Net effect of dilutive securities								260,080	384,721	342,859
Weighted average common shares outstanding - diluted								28,926,557	28,917,048	28,865,384
Income per common share – basic	$ (0.06)	$ 0.02	$ 0.05	$ 0.02	$ 0.04	$ 0.06	$ 0.03	$ 0.01	$ 0.15	$ 0.09
Income per common share – diluted	(0.06)	$ 0.02	$ 0.05	0.02	$ 0.04	$ 0.06	$ 0.03	0.01	0.15	0.08
Exercise price of options outstanding not included in computation of diluted shares (in Dollars per share)	2.53			2.60				$ 2.53	$ 2.60	$ 2.60	$ 2.64
Options [Member]
Schedule of Earnings Per Share, Basic and Diluted [Line Items]
Net effect of dilutive securities								11,443	50,473	109,583
anti-dilutive shares								90,000	90,000
Exercise price of options outstanding not included in computation of diluted shares (in Dollars per share)	3.92			$ 3.92				$ 3.92	$ 3.92
Restricted Stock [Member]
Schedule of Earnings Per Share, Basic and Diluted [Line Items]
Net effect of dilutive securities								248,637	334,248	233,276
Anti-Dilutive Minimum Per Share Price [Member]
Schedule of Earnings Per Share, Basic and Diluted [Line Items]
anti-dilutive shares								17,500
Exercise price of options outstanding not included in computation of diluted shares (in Dollars per share)	$ 1.82							$ 1.82

Inventory (Components Of Invent

Inventory (Components Of Inventory) (Details) - USD ($)	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013
Inventory [Abstract]
Raw material	$ 670,802	$ 839,179
Work in process		77,483
Finished goods	1,834,958	868,270
Inventory, gross	2,505,760	1,784,932
Less: inventory reserves	(13,116)	(39,752)	$ (60,873)	$ (41,133)
Inventory, net	$ 2,492,644	$ 1,745,180

Inventory (Change In Inventory

Inventory (Change In Inventory Reserve) (Details) - USD ($)	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
Inventory [Abstract]
Balance at October 1	$ 39,752	$ 60,873	$ 41,133
Charged to costs and expenses	(8,630)	173,634	37,603
Write-offs	(18,006)	(194,755)	(17,863)
Balance at September 30	$ 13,116	$ 39,752	$ 60,873

Line of Credit (Narrative) (Det

Line of Credit (Narrative) (Details)	Dec. 29, 2015USD ($)	Sep. 30, 2016USD ($)	Sep. 30, 2015USD ($)	Aug. 01, 2015USD ($)
BMO Harris Bank (The Credit Agreement) [Member]
Line of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity	$ 10,000,000
Commitment fee		0.10%
Line of credit facility, expiration date		Dec. 29, 2017
Line of credit facility, amount outstanding		$ 0	$ 0
Pledge percentage		65.00%
Midland States Bank (The Loan Agreement) [Member]
Line of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity				$ 2,000,000
Ratio of total liabilities to total stockholders equity		1
Line of credit facility, interest rate at period end			3.25%
Line of credit penalty	0
Line of credit facility, expiration date		Aug. 1, 2016
Line of credit facility, amount outstanding	$ 0		$ 0
London Interbank Offered Rate (LIBOR) [Member] | BMO Harris Bank (The Credit Agreement) [Member]
Line of Credit Facility [Line Items]
Debt instrument, basis spread on variable rate		2.25%
Inventory [Member] | Midland States Bank (The Loan Agreement) [Member]
Line of Credit Facility [Line Items]
Line of credit facility, percentage of assets borrowing		50.00%
Minimum [Member] | Midland States Bank (The Loan Agreement) [Member]
Line of Credit Facility [Line Items]
Line of credit facility, percentage of assets borrowing		70.00%
Maximum [Member] | Midland States Bank (The Loan Agreement) [Member]
Line of Credit Facility [Line Items]
Line of credit facility, percentage of assets borrowing		80.00%

Operating Leases And Rental E42

Operating Leases And Rental Expense (Narrative) (Details)	12 Months Ended
	Sep. 30, 2016USD ($)ft²
Equipment [Member]
Operating Leased Assets [Line Items]
Operating lease monthly payments	$ 1,265
Chicago, Illinois [Member] | Office Space [Member]
Operating Leased Assets [Line Items]
Area of real estate property | ft²	6,600
Operating lease term	7 years
Operating lease holiday term	7 months
Operating lease abatement term	5 months
Extension of term of lease	5 years
Security deposit	$ 55,000
Chicago, Illinois [Member] | Office Space [Member] | Previous Lease [Member]
Operating Leased Assets [Line Items]
Area of real estate property | ft²	5,100
Operating lease term	5 years
Chicago, Illinois [Member] | Minimum [Member] | Office Space [Member]
Operating Leased Assets [Line Items]
Operating leases escalating monthly payments	$ 5,833
Chicago, Illinois [Member] | Maximum [Member] | Office Space [Member]
Operating Leased Assets [Line Items]
Operating leases escalating monthly payments	$ 9,285
London, England [Member]
Operating Leased Assets [Line Items]
Area of real estate property | ft²	6,400
London, England [Member] | Office Space [Member]
Operating Leased Assets [Line Items]
Area of real estate property | ft²	6,400
Lease Expiration Date	Jun. 1, 2020
Security deposit	$ 59,000
London, England [Member] | Office Space [Member] | Through December 2011 [Member]
Operating Leased Assets [Line Items]
Operating lease quarterly rental payments	13,500
London, England [Member] | Office Space [Member] | January 2012 Through June 2015 [Member]
Operating Leased Assets [Line Items]
Operating lease quarterly rental payments	27,000
London, England [Member] | Office Space [Member] | June 2016 Through June 2020 [Member]
Operating Leased Assets [Line Items]
Operating lease quarterly rental payments	$ 24,000
Selangor D.E., Malaysia [Member]
Operating Leased Assets [Line Items]
Area of real estate property | ft²	45,800
Selangor D.E., Malaysia [Member] | Manufacturing Space [Member]
Operating Leased Assets [Line Items]
Area of real estate property | ft²	45,800
Operating lease renewal term	3 years
Operating lease monthly payments	$ 15,000

Operating Leases And Rental E43

Operating Leases And Rental Expense (Schedule Of Operating Lease Expense, Including Real Estate Taxes And Insurance) (Details) - USD ($)	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
Operating Leased Assets [Line Items]
Operating lease expense	$ 471,132	$ 477,436	$ 444,480
Factory and Office Leases [Member]
Operating Leased Assets [Line Items]
Operating lease expense	455,956	470,049	439,722
Other [Member]
Operating Leased Assets [Line Items]
Operating lease expense	$ 15,176	$ 7,387	$ 4,758

Operating Leases And Rental E44

Operating Leases And Rental Expense (Schedule Of Future Minimum Payments Under Leases) (Details)	Sep. 30, 2016USD ($)
Operating Leases And Rental Expense [Abstract]
2,017	$ 345,301
2,018	401,624
2,019	401,904
2,020	186,305
2,021	110,803
Thereafter	228,298
Total minimum lease payments	$ 1,674,235

Income Taxes (Narrative) (Detai

Income Taxes (Narrative) (Details) - USD ($)	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
Income Tax Expense (Benefit) [Line Items]
Valuation allowance, deferred tax asset, change in amount	$ (276,000)	$ (16,000)	$ 444,000
Unrecognized tax benefits	0	0
Expense for interest and penalties related to uncertain tax positions	0	$ 0	$ 0
Federal [Member]
Income Tax Expense (Benefit) [Line Items]
Operating loss carryforwards	8,105,000
State [Member]
Income Tax Expense (Benefit) [Line Items]
Operating loss carryforwards	$ 7,825,000
U.S. [Member]
Income Tax Expense (Benefit) [Line Items]
Audit tax period	3 years
U.K. [Member]
Income Tax Expense (Benefit) [Line Items]
Operating loss carryforwards	$ 60,863,000
Audit tax period	1 year
Filing date or deadline period after end of accounting period	1 year
Malaysia [Member]
Income Tax Expense (Benefit) [Line Items]
Audit tax period	5 years
Filing date or deadline period after end of accounting period	7 months

Income Taxes (Schedule Of Incom

Income Taxes (Schedule Of Income Before Income Taxes, By Jurisdictions) (Details) - USD ($)	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
Income Taxes [Abstract]
Domestic	$ 1,068,580	$ 4,524,499	$ 2,837,835
Foreign	1,745,336	2,162,541	1,119,356
Income before income taxes	$ 2,813,916	$ 6,687,040	$ 3,957,191

Income Taxes (Reconciliation Of

Income Taxes (Reconciliation Of Income Tax Expense (Benefit)) (Details) - USD ($)	3 Months Ended								12 Months Ended
	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
Income tax expense at statutory rates									$ 957,000	$ 2,274,000	$ 1,345,000
State income tax, net of federal benefits									149,000	362,000	248,000
Non-deductible expenses- other									50,000	51,000	(5,000)
Non-deductible business acquisition expense									556,000
Effect of lower foreign income tax rates									(305,648)	(351,244)	(175,632)
Effect of reinvestment allowance - Malaysia											(9,000)
Effect of export allowance - Malaysia										(85,000)
Effect of change in Illinois tax rate										202,000
Effect of conversion of charitable contribution to NOL										(36,174)
Other									87,839	(59,578)	56,762
Change in valuation allowance									(18,000)	(16,000)	64,000
Income tax expense	$ 1,436,351	$ 231,211	$ (27,824)	$ 829,453	$ 79,229	$ 284,900	$ 1,306,445	$ 670,430	2,469,191	$ 2,341,004	$ 1,524,130
U.K. [Member]
Effect of lower foreign income tax rates									1,251,000
Change in valuation allowance									$ (258,000)

Income Taxes (Summary Of Federa

Income Taxes (Summary Of Federal And State Income Tax Provision (Benefit)) (Details) - USD ($)	3 Months Ended								12 Months Ended
	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
Components of Income Tax Expense (Benefit) [Line Items]
Subtotal - Deferred									$ 2,054,817	$ 1,925,739	$ 1,012,334
Subtotal - Current									414,374	415,265	511,796
Income tax expense	$ 1,436,351	$ 231,211	$ (27,824)	$ 829,453	$ 79,229	$ 284,900	$ 1,306,445	$ 670,430	2,469,191	2,341,004	1,524,130
U.S. [Member]
Components of Income Tax Expense (Benefit) [Line Items]
Deferred - Federal									881,000	1,856,000	561,000
Current - Federal									104,000	83,606	219,000
U.K. [Member]
Components of Income Tax Expense (Benefit) [Line Items]
Deferred - Foreign									1,162,000	162,000	496,000
Malaysia [Member]
Components of Income Tax Expense (Benefit) [Line Items]
Deferred - Foreign									11,817	(92,261)	(44,666)
Current - Foreign									$ 310,374	$ 331,659	$ 292,796

Income Taxes (Significant Compo

Income Taxes (Significant Components Of Deferred Tax Assets And Liabilities) (Details) - USD ($)	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Components Of Deferred Tax Assets And Liabilities [Line Items]
Federal net operating loss carryforwards	$ 2,756,000	$ 4,428,000
State net operating loss carryforwards	400,000	644,000
AMT credit carryforward	489,000	390,000
Foreign net operating loss carryforwards - U.K.	10,955,000	12,388,000
Foreign capital allowance - U.K.	112,000	114,000
Restricted stock - U.K.	1,000
Share-based compensation	101,000	128,000
Deemed Dividend - Malaysia	942,000
Gross deferred tax assets	15,790,850	18,113,097
Valuation allowance for deferred tax assets	(2,299,000)	(2,575,000)
Net deferred tax assets	13,491,850	15,538,097
Deferred Tax Liabilities:
Foreign capital allowance – Malaysia	(119,919)	(111,349)
Net deferred tax assets	13,371,931	15,426,748
Malaysia [Member]
Components Of Deferred Tax Assets And Liabilities [Line Items]
Other, net	9,850	13,097
U.S. [Member]
Components Of Deferred Tax Assets And Liabilities [Line Items]
Other, net	$ 25,000	$ 8,000

Income Taxes (Schedule Of Defer

Income Taxes (Schedule Of Deferred Tax Amounts Classified In Balance Sheets) (Details) - USD ($)	Sep. 30, 2016	Sep. 30, 2015
Components Of Deferred Tax Assets And Liabilities [Line Items]
Current assets	$ 2,025,000	$ 1,016,000
Long-term assets	11,457,000	14,509,000
Long-term liability – Malaysia	(110,069)	(98,252)
Net deferred tax assets	13,371,931	15,426,748
U.S. [Member]
Components Of Deferred Tax Assets And Liabilities [Line Items]
Current assets	2,020,000	854,000
Long-term assets	2,693,000	4,740,000
U.K. [Member]
Components Of Deferred Tax Assets And Liabilities [Line Items]
Current assets	5,000	162,000
Long-term assets	$ 8,764,000	$ 9,769,000

Income Taxes (Changes In Valuat

Income Taxes (Changes In Valuation Allowance For Deferred Tax Assets) (Details) - Valuation Allowance of Deferred Tax Assets [Member] - USD ($)	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
Valuation and Qualifying Accounts Disclosure [Line Items]
Balance at October 1	$ 2,575,000	$ 2,591,000	$ 2,147,000
Charged to Costs and Expenses	(276,000)	(16,000)	432,000
Deductions/Other			12,000
Balance at September 30	$ 2,299,000	$ 2,575,000	$ 2,591,000

Equity And Share-Based Paymen52

Equity And Share-Based Payments (Narrative) (Details)	12 Months Ended
	Sep. 30, 2016USD ($)$ / sharesshares	Sep. 30, 2015USD ($)shares	Sep. 30, 2014USD ($)shares	Sep. 30, 2013shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants in period	17,500
Share-based compensation | $	$ 499,873	$ 489,689	$ 858,615
Cashless options, exercises in period			30,000
Cash options, exercises in period			30,000
Proceeds from exercise of stock options | $			$ 117,600
Options, exercises in period, intrinsic value | $	$ 0	$ 0	$ 154,000
Grants in period	101,250	293,500	213,576
Cash election	27,666
Stock price | $ / shares	1.58
Share price | $ / shares	$ 1.22
Fair value of awards granted | $	$ 153,000	$ 499,000	$ 1,665,000
Unrecognized compensation expense | $	0
Unrecognized compensation expense, stock options | $	$ 8,601
Shares forfeited in period		58,250	250
Shares exercised	0	0	60,000
Unvested shares	189,970	283,722	141,435	33,502
Unrecognized compensation expense, period for recognition	1 year 6 months
Class of warrant or right, outstanding	0	0
Preferred stock, issued	0	0
Preferred stock, outstanding	0	0
Preferred Class A [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Preferred stock, shares authorized	5,000,000
Preferred stock, par or stated value per share (in Dollars per share) | $ / shares	$ 0.01
Preferred stock, issued	0	0
Preferred stock, outstanding	0	0
Preferred Class A Series 1 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Preferred stock, shares authorized	1,040,000
Preferred Class A Series 2 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Preferred stock, shares authorized	1,500,000
Preferred Class A Series 3 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Preferred stock, shares authorized	700,000
Preferred Class B [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Preferred stock, shares authorized	15,000
Preferred stock, par or stated value per share (in Dollars per share) | $ / shares	$ 0.50
Preferred stock, issued	0	0
Preferred stock, outstanding	0	0
Rights under Continued Employment or Service [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants in period	13,498
Common Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance of common stock upon cashless exercise of options			16,963
Stock issued during period, shares, share-based compensation, net of forfeitures	81,418	233,867	216,863
Issuance of common stock upon exercise of stock options (in Shares)			30,000
Warrants issued during the period	0	0	0
Common Stock [Member] | Cashless [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance of common stock upon cashless exercise of options			16,963
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation | $	$ 495,000	$ 437,000	$ 859,000
Cash election	27,666
Stock price | $ / shares	1.32
Unrecognized compensation expense | $	$ 287,000
Shares forfeited in period	0	58,250	250
Unvested shares	190,000
Unrecognized compensation expense, period for recognition	1 year 10 months 21 days
Accrued expenses from shares not yet issued | $	$ 29,000	$ 23,000	$ 256,000
Tax benefit of stock-based compensation expense | $	115,000	114,000	204,000
Tax expense for stock-based compensation expenses | $	$ 141,000	190,000	0
Minimum [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	1 year
Award requisite service period	1 year
Maximum [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	3 years
Award requisite service period	3 years
2008 Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized	2,000,000
Number of shares granted	1,471,302
Award expiration period	10 years
Award vesting period	3 years
Unrecognized compensation expense, stock options | $	$ 5,000	$ 0	$ 0
2008 Stock Incentive Plan [Member] | Share-based Compensation Award, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rights, percentage per month	2.80%
2008 Stock Incentive Plan [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares granted	167,500
Grants in period	17,500
Award expiration period	10 years
Award vesting period	2 years
2008 Stock Incentive Plan [Member] | Employee Stock Option [Member] | Share-based Compensation Award, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	1 year
Shares expected to vest	8,750
1997 Stock Option Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant	0
Award expiration period	10 years
Award vesting period	3 years
Expiration date	Dec. 31, 2006
1997 Stock Option Plan [Member] | Share-based Compensation Award, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rights, percentage per month	2.80%

Equity And Share-Based Paymen53

Equity And Share-Based Payments (Weighted Average Assumptions For Options Granted) (Details)	12 Months Ended
	Sep. 30, 2016$ / shares
Equity And Share-Based Payments [Abstract]
Expected Volatility	43.19%
Expected Dividend Yield	0.00%
Risk-free Interest Rate	1.53%
Expected Term (in years)	6 years
Fair Value of Options Granted	$ 0.78

Equity And Share-Based Paymen54

Equity And Share-Based Payments (Summary Of Stock Options Outstanding And Exercisable) (Details) - $ / shares	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
Equity And Share-Based Payments [Abstract]
Shares, Outstanding at September 30	180,000	180,000	240,000
Shares, Granted	17,500
Shares, exercised	0	0	(60,000)
Shares, Forfeited
Shares, Outstanding at September 30	197,500	180,000	180,000
Shares, Exercisable on September 30, 2015	180,000
Weighted Average Exercise Price Per Share, Outstanding (in Dollars per share)	$ 2.60	$ 2.60	$ 2.64
Weighted Average Exercise Price Per Share, Granted (in Dollars per share)	1.82
Weighted Average Exercise Price Per Share, Forfeited (in Dollars per share)
Weighted Average Exercise Price Per Share, Exercised (in Dollars per share)			2.79
Weighted Average Exercise Price Per Share, Outstanding (in Dollars per share)	2.53	$ 2.60	$ 2.60
Weighted Average Exercise Price Per Share, Exercisable on September 30, 2015 (in Dollars per share)	$ 2.60
Weighted Average Remaining Contractual Term, Outstanding at September 30, 2015 (years)	2 years 22 days
Options Exercisable, Weighted Average Remaining Life (years)	1 year 4 months 2 days

Equity And Share-Based Paymen55

Equity And Share-Based Payments (Summary Of Non-Vested Stock Activity) (Details)	12 Months Ended
	Sep. 30, 2016$ / sharesshares	Sep. 30, 2015$ / sharesshares	Sep. 30, 2014$ / sharesshares	Sep. 30, 2013$ / shares
Equity And Share-Based Payments [Abstract]
Total Outstanding Shares | shares	283,722	141,435	33,502
Stock Granted | shares	101,250	293,500	213,576
Vested | shares	(167,336)	(92,963)	(105,393)
Forfeited | shares		(58,250)	(250)
Cash Election | shares	(27,666)
Total Outstanding Shares | shares	189,970	283,722	141,435
Weighted Average Grant -Date Fair Value (in Dollars per share) | $ / shares	$ 1.51	$ 2.31	$ 7.30	$ 6.80
Weighted Average Grant -Date Fair Value, Stock Granted (in Dollars per share) | $ / shares	1.52	1.70	7.80
Weighted Average Grant -Date Fair Value, Vested (in Dollars per share) | $ / shares	$ 2.73	4.70	8.15
Weighted Average Grant -Date Fair Value, Forfeited (in Dollars per share) | $ / shares		7.36	9.68
Weighted Average Grant-Date Fair Value, Cash Election ( in Dollars per share) | $ / shares	1.58
Weighted Average Grant -Date Fair Value (in Dollars per share) | $ / shares	$ 1.51	$ 2.31	$ 7.30

Stock Repurchase Program (Narra

Stock Repurchase Program (Narrative) (Details) - shares	12 Months Ended
	Sep. 30, 2016	Jan. 17, 2007
Equity, Class of Treasury Stock [Line Items]
Number of shares authorized to be repurchased		1,000,000
Stock repurchased during period, shares	2,183,704
Maximum repurchases allowed under provision through calendar year	450,000
Maximum repurchases allowed under provision annually per individual	50,000
Maximum [Member]
Equity, Class of Treasury Stock [Line Items]
Number of shares authorized to be repurchased	3,000,000

Stock Repurchase Program (Total

Stock Repurchase Program (Total Repurchase Transactions) (Details) - shares	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
Stock Repurchase Program [Abstract]
Open market repurchase transactions			165,000
Private repurchase transactions		250	4,000
Total repurchase transactions		250	169,000

Stock Repurchase Program (Sched

Stock Repurchase Program (Schedule Of Repurchase Activity) (Details) - $ / shares	12 Months Ended			72 Months Ended	117 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2012	Sep. 30, 2016
Equity, Class of Treasury Stock [Line Items]
Total Number of Shares Purchased		250	169,000
Aggregate Number of Shares Purchased As Part of Publicly Announced Program	2,183,704
Treasury Stock [Member]
Equity, Class of Treasury Stock [Line Items]
Total Number of Shares Purchased		250	169,000	2,014,454	2,183,704
Average Price Paid Per Share		$ 3.80	$ 4.37	$ 3.51	$ 3.57
Aggregate Number of Shares Purchased As Part of Publicly Announced Program	2,183,704	2,183,704	2,183,454	2,014,454	2,183,704
Maximum Number of Shares that May Yet be Purchased Under the Program	816,296	816,296	816,546	985,546	816,296

Employee Benefit Plan (Details)

Employee Benefit Plan (Details) - USD ($)	1 Months Ended	12 Months Ended
	Mar. 31, 2014	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
Defined Contribution Plan [Line Items]
Defined Benefit Plan, Contributions by Employer (in Dollars)		$ 33,000	$ 37,000	$ 31,000
United States Postretirement Benefit Plan of US Entity [Member]
Defined Contribution Plan [Line Items]
Defined Contribution Plan, Maximum Annual Contributions Per Employee, Amount (in Dollars)		$ 15,500
Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent		100.00%
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay		3.00%
United States Postretirement Benefit Plan of US Entity [Member] | U.K. [Member]
Defined Contribution Plan [Line Items]
Defined Benefit Plan, Contributions by Employer (in Dollars)		$ 23,000	$ 26,000	$ 6,000
Foreign Postretirement Benefit Plan [Member] | U.K. [Member]
Defined Contribution Plan [Line Items]
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay	3.00%

Industry Segments And Financi60

Industry Segments And Financial Information About Foreign And Domestic Operations (Schedule Of Operations By Geographic Area) (Details)

3 Months Ended

12 Months Ended

Sep. 30, 2016USD ($)

Jun. 30, 2016USD ($)

Mar. 31, 2016USD ($)

Dec. 31, 2015USD ($)

Sep. 30, 2015USD ($)

Jun. 30, 2015USD ($)

Mar. 31, 2015USD ($)

Dec. 31, 2014USD ($)

Sep. 30, 2016USD ($)segment

Sep. 30, 2015USD ($)

Sep. 30, 2014USD ($)

Revenues from External Customers and Long-Lived Assets [Line Items]

Number of Reportable Segments | segment

1

Net revenues to external customers

$ 3,563,106

$ 5,560,776

$ 4,772,801

$ 8,230,659

$ 7,154,985

$ 7,813,207

$ 10,977,467

$ 6,659,206

$ 22,127,342

$ 32,604,865

$ 24,490,586

Long-Lived Asset

8,852,000

1,377,000

8,852,000

1,377,000

Brazil [Member]

Revenues from External Customers and Long-Lived Assets [Line Items]

Net revenues to external customers

[1]

6,008,000

14,841,000

[2]

Zimbabwe [Member]

Revenues from External Customers and Long-Lived Assets [Line Items]

Net revenues to external customers

3,305,000

[1]

2,696,000

[2]

2,064,000

[2]

U.S. [Member]

Revenues from External Customers and Long-Lived Assets [Line Items]

Net revenues to external customers

2,464,000

[1]

2,029,000

2,381,000

Long-Lived Asset

7,963,000

123,000

7,963,000

123,000

South Africa [Member]

Revenues from External Customers and Long-Lived Assets [Line Items]

Net revenues to external customers

1,117,000

2,331,000

2,928,000

[1],[2]

Angola [Member]

Revenues from External Customers and Long-Lived Assets [Line Items]

Net revenues to external customers

[2]

2,477,000

[1]

DR of Congo [Member]

Revenues from External Customers and Long-Lived Assets [Line Items]

Net revenues to external customers

[2]

2,185,000

Tanzania [Member]

Revenues from External Customers and Long-Lived Assets [Line Items]

Net revenues to external customers

[2]

1,936,000

Malaysia [Member]

Revenues from External Customers and Long-Lived Assets [Line Items]

Net revenues to external customers

[2]

Long-Lived Asset

796,000

1,134,000

796,000

1,134,000

U.K. [Member]

Revenues from External Customers and Long-Lived Assets [Line Items]

Net revenues to external customers

[2]

[1]

[1]

Long-Lived Asset

$ 93,000

$ 120,000

93,000

120,000

Other Countries [Member]

Revenues from External Customers and Long-Lived Assets [Line Items]

Net revenues to external customers

[2]

$ 9,233,000

$ 10,708,000

$ 10,520,000

Net Revenues Less Than Five Percent [Member] | Total Revenue [Member]

Revenues from External Customers and Long-Lived Assets [Line Items]

Concentration risk, percentage

5.00%

Net Revenues Exceeding Ten Percent [Member] | Total Revenue [Member]

Revenues from External Customers and Long-Lived Assets [Line Items]

Concentration risk, percentage

10.00%

[1]

Exceeds 10 percent of total net revenues.

[2]

Less than 5 percent of total net revenues.

Contingent Liabilities (Narrati

Contingent Liabilities (Narrative) (Details) $ in Millions	Sep. 30, 2016USD ($)
Contingent Liabilities [Abstract]
Loss contingency, range of possible loss, maximum	$ 10

Dividends (Narrative) (Details)

Dividends (Narrative) (Details) $ / shares in Units, $ in Millions	9 Months Ended	12 Months Ended				24 Months Ended
	Feb. 06, 2013item$ / shares	Sep. 30, 2016item	Sep. 30, 2014USD ($)	May 07, 2014item$ / shares	Sep. 30, 2013USD ($)	Feb. 09, 2012item$ / shares
Dividends [Abstract]
Number of dividends paid | item	4	18		5		9
Dividends payable, amount per share | $ / shares	$ 0.06			$ 0.07		$ 0.05
Cumulative dividends paid			$ 29.4
Payments of dividends			$ 6.1		$ 7.5

Quarterly Financial Data (Detai

Quarterly Financial Data (Details) - USD ($)	3 Months Ended								12 Months Ended
	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
Quarterly Financial Data [Abstract]
Net revenues	$ 3,563,106	$ 5,560,776	$ 4,772,801	$ 8,230,659	$ 7,154,985	$ 7,813,207	$ 10,977,467	$ 6,659,206	$ 22,127,342	$ 32,604,865	$ 24,490,586
Gross profit	1,868,559	3,233,193	2,845,395	5,402,337	4,123,644	4,632,535	6,394,107	3,819,673	13,349,484	18,969,959	13,121,478
Operating expenses	2,161,546	2,384,674	2,774,970	3,009,782	3,362,327	3,178,687	3,444,714	2,365,824	10,330,972	12,351,552	9,197,566
Income tax expense (benefit)	1,436,351	231,211	(27,824)	829,453	79,229	284,900	1,306,445	670,430	2,469,191	2,341,004	1,524,130
Net income (loss)	$ (1,750,941)	$ 570,258	$ 35,045	$ 1,490,363	$ 702,571	$ 1,170,974	$ 1,667,574	$ 804,917	$ 344,725	$ 4,346,036	$ 2,433,061
Net income (loss) per common share - basic	$ (0.06)	$ 0.02		$ 0.05	$ 0.02	$ 0.04	$ 0.06	$ 0.03	$ 0.01	$ 0.15	$ 0.09
Net income (loss) per common share - diluted	$ (0.06)	$ 0.02		$ 0.05	$ 0.02	$ 0.04	$ 0.06	$ 0.03	$ 0.01	$ 0.15	$ 0.08

Subsequent Events (Narrative) (

Subsequent Events (Narrative) (Details)	Nov. 01, 2016USD ($)ft²	Oct. 31, 2016USD ($)item$ / sharesshares	Sep. 30, 2016USD ($)shares	Sep. 30, 2015USD ($)shares	Sep. 30, 2014USD ($)shares
Common stock			29,090,250	29,008,832
Preferred stock			0	0
FHC common stock issued			31,273,954	31,192,536
Shares vested			167,336	92,963	105,393
Fair value of awards | $			$ 455,624	$ 722,650	$ 909,450
Subsequent Event [Member] | The APP Merger [Member]
Aquisition agreement date		Oct. 31, 2016
Common stock		2,000,000
Percentage of FHC Common Stock		45.00%
Estimated purchase price | $		$ 22,676,737
Closing price per share | $ / shares		$ 0.95
FHC common stock issued		23,870,249
Issued stock awards		760,000
Fair value of awards | $		$ 722,000
Weighted average life		5 years 9 months
Area of real estate property | ft²	2,600
Operating lease term	3 years
Operating lease monthly payments | $	$ 9,240
Annual increase percentage	4.00%
Number of Complaints Filed | item		2
Subsequent Event [Member] | The APP Merger [Member] | Restricted Stock [Member]
Closing price per share | $ / shares		$ 0.95
Shares vested		221,549
Fair value of awards | $		$ 210,472
Subsequent Event [Member] | The APP Merger [Member] | Renewal Option One [Member]
Extension of term of lease	3 years
Subsequent Event [Member] | The APP Merger [Member] | Renewal Option Two [Member]
Extension of term of lease	3 years
Subsequent Event [Member] | The APP Merger [Member] | Share-based Compensation Award, Tranche One [Member] | Restricted Stock [Member]
Issued stock awards		380,000
Subsequent Event [Member] | The APP Merger [Member] | Share-based Compensation Award, Tranche Two [Member] | Restricted Stock Units & Stock Appreciation Rights [Member]
Issued stock awards		380,000
Subsequent Event [Member] | The APP Merger [Member] | The Financial Advisor Warrant [Member]
Warrant to purchase common stock shares		2,585,379
Warrant term		5 years
Fair value of warrant | $		$ 723,906
Subsequent Event [Member] | The APP Merger [Member] | Ten-Day Period, Original Announcement Of Merger [Member]
Strike price per share | $ / shares		$ 1.93
Subsequent Event [Member] | The APP Merger [Member] | Five Day Period, Prior To Announcement [Member]
Strike price per share | $ / shares		$ 1.02
Subsequent Event [Member] | Class A Convertible Preferred Stock [Member] | The APP Merger [Member]
Preferred stock		546,756
Shares issued upon conversion		40
Liquidation preference price per share | $ / shares		$ 1
Liquidation preference value of shares | $		$ 546,756
Redemption price per share | $ / shares		$ 1
Voting rights		The Series 4 Preferred Stock has one vote per share and will generally vote with the Company's common stock on a one share to one share basis

Subsequent Events (Schedule of

Subsequent Events (Schedule of Pro forma of Combined Entity) (Details) - Subsequent Event [Member]	Oct. 01, 2016USD ($)
October 1, 2013 - September 30, 2014
Net revenues	$ 24,490,586	[1]
Net income (loss)	2,388,785	[1]
October 1, 2014 - September 30, 2015
Net revenues	32,621,548
Net income (loss)	3,028,101
October 1, 2015 - September 30, 2016
Net revenues	22,143,411
Net income (loss)	$ (2,434,976)
[1]	Includes the results for APP from the date of inception, June 9, 2014 through September 30, 2014.